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1. INTRODUCTION 
Hypertension is one of the most common life style disorder. It is a one of the 
most preventable causes of premature morbidity and mortality in worldwide
 [1]
. This 
disease being closely associated with diet, it is conceivable that food is conductive to 
preventing and enhancing such diseases as an adjunct to drug therapy. Therefore we 
tried to develop a novel food protein with anti-hypertensive activity for the dietetics of 
hypertension. 
Primary hypertension is remarkably common in the population and the 
prevalence is strongly influenced by age and life style factors. According to research 
surveys based on Medline, web of science and Scopus databases, 25% rural and 33% 
urban Indians are hypertensive
 [2]
. It is estimated that the number of people living with 
hypertension will be increased as more than 1.56 billion by the year 2025
[3]
.  
Systemic hypertension is the persistent rise of basal blood pressure above the 
arbitrary level of 140/90 mmHg recorded on 3 or more successive occasions. Blood 
pressure is quantified as diastolic and systolic pressure measured in millimetres of 
Mercury (mm hg). The diastolic pressure represents the pressure during ventricular 
relaxation in diastole, where as the systolic pressure represents the peak pressure due to 
ventricular contractions during systole.  
Primary hypertension is remarkably common in the population and the 
prevalence is strongly influenced by age and life style factors. Systolic pressure 
elevation is the more dominant feature of hypertension in older patients and diastolic 
pressure more commonly elevated in younger patients. Many diseases fall under the 
category of “Silent killers”, including Hypertension is one among them. Cardiovascular 
and cerebro vascular diseases are the major risk factors seen in patients of 
Hypertension
[4]
. 
In worldwide raised blood pressure is estimated to cause 7.5 million deaths, 
about 12.8% of the total of all deaths. Globally the overall prevalence of raised blood 
pressure in adults aged 25 and over was around 40%  in 2008. In India high blood 
pressure is a major public health problem and its prevalence is rapidly increasing among 
both urban and rural populations. In fact, hypertension is the most prevalent chronic 
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disease in India. 2012 studies show that for every known person with hypertension there 
are two persons with either undiagnosed hypertension or prehypertension.  
The morbidity of prolonged hypertension damages the blood vessels of heart 
results in atherosclerosis, stroke, kidney disease, diabetes mellitus, metabolic syndrome, 
preeclampsia, erectile dysfunction and retinopathy. Anti hypertensive act by influencing 
the BP regulatory systems, the autonomic nervous system, rennin-angiotensin system, 
calcium channels.   
World hypertension day (WHD) –MAY 17th (Healthy heart beat - Healthy 
blood pressure)
[5]
. 
The purpose of   world hypertension day is to promote public awareness of 
hypertension and to encourage the citizens of all the countries to prevent and control 
this silent killer, in the modern epidemic.WHD has been recommended by World 
hypertension league (WHL) that blood pressure should be less than 140/90 mmHg for 
general population
[6]
. 
A number of safe and effective medication are available for treatment of high 
blood pressure, Current treatment strategies for hypertensive includes, 
1. Diuretics 
 Thiazides                -hydrocholorothiazide, chlorthalidone, 
indapamide 
 Loop diuretics  - Frusemide, bumetanide, torsemide 
 K+ Sparing diuretics   - Spironolactone, amiloride, triamterene. 
2. Drugs acting on renin angiotensin system  
 Angiotensin converting enzyme inhibitors 
-Captopril, enalapril, lisinopril, ramipril. 
 Angiotensin II receptor antagonists - Losartan, valsartan. 
 Renin inhibitor        - Aliskiren. 
3. Sympatholytics 
 Centrally acting drugs - Guanfacine, Clonidine, Guanabenz, 
Methyldopa. 
 Ganglion blockers -Trimethaphan,  
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 Adrenergic neuron blockers -Guanethidine, reserpine. 
 Adrenergic receptor blockers- 
α-blockers -Prazosin, phenoxybenzamine 
β-blockers -Propranolol, atenolol. 
Mixed α and β blockers-Labetalol,carvedilol 
 Ca ++ channel blockers  - Nifedipine, nicardipine, amlodipine, 
verapamil 
5. Vasodilators 
 Arteriolar dilators-Hydralazine, minoxidil 
 Arteriolar and venular dilators-Sodium nitroprusside 
Though such drugs showing better results in treating hypertension some serious 
adverse effects such as drowsiness, parotid gland swelling and pain, constipation, fluid 
retention, impotence, tremors, sweating, tachycardia, palpitation, hypotension always 
seen towards the usage of those drugs
[7]
. In order to negotiate those adverse effects 
observed for the usage of modern medicines there is an emergence need for the medical 
world to treat the highly prevalence disease hypertension. 
 Herbals and herbo-mineral formulations are always fame because of its 
therapeutic source without causing adverse effects. Now  the  people among the world is 
awakened about the clinical importance in use of herbal medicines. At the same time 
even herbal medicines are considered as effective as well as good without causing any 
harmful effects, due to various changes in our environment here is a need to confirm the 
safe use of herbal drugs. Siddha system is an immemorial system with several 
admirable properties. It’s not only cures disease but also helps in the prevention of 
disease, thereby increasing the longevity of life.  
Hypertension described in modern medicine correlates with that of  “Kuruthi 
azhal noi” as mentioned in Siddha literature. It is also known as “Raktha pitham”. 
“Prevention is better than cure” which is the main target of Siddha system. Siddha 
medicines were formulated by using the theory of “Arusuvaikal” and it includes the 
material ingredients such as plant, animal products, metals and minerals. According to 
Siddha system the herbo-mineral preparations are having more potent therapeutic value. 
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In Siddha medical system, So many compounds were formulated by the great siddhars 
for the management of “Kuruthi Azhal Noi”.  
In Siddha system there is a slogan which is “                
   ” which indicates that the role of food habits plays a major role in the 
management of diseases for better cure. Each food has some characteristic property   
functioning in role of treating diseases especially lifestyle disease like hypertension. 
“Munthirikai chooranam” is a herbo-mineral formulation was indicated in 
Siddha text “Aathma Ratchamirtha Vaithiya Saara Sangiragam” for the treatment of 
Ratha Pitham, Peripheral neuritis, Vertigo
 [8]
. The  Siddha  term “Ratha Pitham” which 
is described for the condition of pathology of Hypertension. Even though the herbal and 
herbo-minerals are safe, proper scientific validation is needed to ensure its safety and 
efficacy for better clinical use. Since there are no scientific backgrounds regarding the 
anti-hypertensive activity of this novel Siddha formulation “Munthirikai Chooranam”.   
Hence the author is interested in doing the Preclinical Evaluation Of 
“Munthirikai Chooranam” For Its Anti-Hypertensive, Diuretics, Anti-Oxidant 
Activities. In addition to that going to create finger prints through  physico-chemical 
and bio chemical characterization to standardize this drug “Munthirikai chooranam” in 
a scientific way. 
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2. AIM AND OBJECTIVES 
  
AIM 
The aim of this treatise is to Evaluate  the Anti-hypertensive, Diuretic and  Anti 
-oxidant Activity of  Munthirikai Chooranam  and  going to  create the fingerprints to 
standardize this medicine with reference to the authentic drugs. 
 
OBJECTIVES: 
 
The key objectives of the study are: 
 
 Collection of various Siddha and modern literature relevant to the study. 
 Preparing the drug according to Siddha classical text. 
 Subjecting the drug into physico-chemical standardization. 
 Analyzing the drug chemically for detection of acid and basic radicals. 
 Focusing the drug for analytical assessment through sophisticated analytical 
modern techniques like FTIR, ICPOES, SEM, XRD 
 Studying the toxicity profile of Munthirikai chooranam according to OECD 
guidelines. 
 Evaluation the pharmacological study of the test drug Munthirikai Chooranam 
through the following activities,  
 Anti-hypertensive, Diuretic Activities in wistar albino rats  
 Anti Oxidant Of  - Through DPPH assay  
 Evaluation of anti-microbial load for this formulation. 
 Analyzing all the above study results to evaluate the benefits of Munthirikai 
Chooranam   
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                                    3. REVIEW OF LITERATURE  
                   3.1 Drug Review 
           3.1.1 Gunapadam aspect[9]  
Munthirikai pazham (Vitis vinifera)  
Alternative names 
 Aravaram, Kodimunthiri, Kodimunthirikai, Munthirikai, Thrakshai,  Madhurasam,      
Koothirikai Thirakam, Paloththamai. 
Vernacular names 
English :  Grapes, Common grape-vine, winegrape, Europeangrape. 
Telugu  :  Draksha 
Sanskrit :  Draksha 
Hindi   :  Munakha 
Malayalam :  Draksha 
Part used  :  Leaves, Fruit  
Suvai          : Inippu 
Thanmai    : Thatpam 
Pirivu         : Inippu 
Action 
 Refrigerant 
 Nutritive 
 Demulcent 
 Diuretic 
 Tonic 
 Laxative 
 Astringent         
Uses : It gives strength for cardiac musculature.               
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Thipilli moolam (Root of Piper longum) 
Alternative name 
Ambinadi,Kiranthiver,Kiranthikam,Thanman,Thanmoolam,Thippilikattai,Thaesavaram, 
Nathikaranthai,Narukuvaeru,Narukkuthippili,Kandaththippili,Modiver.  
Vernacular names 
English           :  Long - pepper - Root 
Telugu :  Pippili-mulam 
 Sanskrit :  Pipalee-moola  
Hindi    :  Felfelai-maya 
Malayalam :  Kattu-thippili 
Part used      :   Root   
Properties 
Suvai              :   Inippu 
Thanmai        :  Thatpam 
Pirivu            :   Inippu 
General character 
                                            
                               -        
                                     
                                .  
                                                  -                 
Actions  
 Stomachic    
Uses       
 It is used in the treatment of cough, diarrhoea. 
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Thiri kadugu 
Chukku  (Zingiber officinale) 
Alternative names 
 Arukkan, Sundi, Sondi, Vidamoodiya Amirtham, Verkombu. 
Vernacular name 
English :  Dried Ginger 
Telugu :  Sondi 
Malayalam :  Chukku 
Sanskrit :  Nagaram 
Hindi   :  Sonth 
Part  used      :  Tuber 
Properties 
Suvai  : Karppu  
Thanmai  : Veppam 
Pirivu  :  Karppu 
General character 
                                         
                            –      
                                     
                            . 
                                         -                
Actions 
 Carminative  
 Stimulant 
 Stomachic 
Uses     :      It is used in the treatment of Ulcer, Cough, Cold and Anaemia. 
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Milagu (Piper nigrum) 
Alternative names 
 Kari, Kaayam, Maasam, Kurumilagu, Malayalam 
Vernacular name 
English           :  Black Pepper 
Telugu            :  Miriyalu 
Malayalam :   Kurumulakku 
Sanskrit :   Marucha 
Hindi  :   Kallirmirch 
Part used        :   Seed, Climber 
Properties 
Suvai             :  Kaippu, Karppu  
Thanmai       :  Veppam 
Pirivu            :  Karppu 
General character 
                                       
                               -      
                                         
                                           .  
-             
Actions 
   Stimulant 
 Acrid 
 Anti-dote 
Uses: It is used in the treatment of Ulcer, Cough, Cold, Anaemia and Hemiplegia. 
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Thippili (Piper nigrum) 
Alternative names 
Aarkathi, Kaman, Saram, Aathi marunthu, Vaitheki. 
Vernacular name 
English          :   Long pepper 
Telugu           :   Pippilu 
Malayalam    :   Thipili 
Sanskrit         :   Papal         
Part used :  Seed, Fruit 
Properties 
Suvai              :   Inippu 
Thanmai        :   Thatppam 
Pirivu             :   Inippu 
General character 
                                 
                               –        
                                         
                             . 
                                                -             
Actions 
 Carminative 
 Stimulant 
 Stomachic 
Uses 
         It is used in the treatment of Ulcer, Cough, Cold, Anaemia, ENT diseases,  
Headache. 
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Sengkazhunir (Nymphaea alba) 
Alternative names 
Urpalam, Kuvalai, Kuvalaiyam, Kazhunir. 
Vernacular names 
  English :  Water lily 
  Telugu :  Nirucancha 
  Malayalam :  Chenkazhuneer 
Part used   :  Whole plant 
Properties 
  Taste        :  Sweet 
  Character :  coolant 
  Division :  Sweet 
Actions 
 Anti-pitta 
 Refrigerant 
General character 
   “                             
                         –       
                        
                   ”. 
       -               
        
Uses 
 Infusion- used to treat thirst and dry powder along with sugar it cures the 
loss of taste sensation. 
Vetiver (Vetiveria zizanioides) 
Alternative names :Vetiver,Vizhal ver,Viranam,Kuru ver 
Vernacular name 
English :   Cuscus grass 
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Telugu  :   Vattiveri 
Malayalam  :   Veti-veru 
Sanskrit :   Usheera veeranam         
Hindi   :   Balah 
Part used :    Ver 
Properties 
Suvai          : Inippu 
Thanmai    : Thatppam 
Pirivu         :  Inippu 
General character 
                                                    
                                        
                                            
                                              . 
-               . 
Actions 
 Tonic 
 Diuretic 
 Febrifuge 
 Stimulant 
Uses 
         It is used in the treatment of Hypertension, Jaundice, Eye diseases, Fever 
Chandanam (Santalum album) 
Vernacular names 
  Eng name      :   Sandalwood 
  San name      :   Chandanam 
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  Tel name       :   Gandeapu-chkka 
  Mal name      :   Chandana 
  Hindi name :   Chandan 
Part  used  :  Sandalwood, Sandal oil 
Properties 
  Suvai      :  Bitter, Mild Astringent 
  Thanmai  : Coolant, Hot  
  Pirivu       : Sweet, Acrid 
Action 
 Alternative 
  Diuretic 
  Diaphoretic 
  Stimulant 
  Disinfectant 
 Astringent 
 Cooling 
General character 
 “க ோதில் சந்தனஞ் சகீதோஷ்ணங் க ோண்டிருக்கும் 
  வோதபித்தம் ஐயம்மனப் பிரமம – ஓதுசுரம் 
  கம ம்தனித் தோ ம்கவப்பு கசோறியும் கபோக்கும் 
  ஆ ந்தனக் குறுதி யோம்”. 
- அ த்தியர் குணவோ டம் 
Uses  
Decoction of sandal wood powder used to treat in Fever, Tachycardia and 
decreases the pulse rate. 
 
Also used to treat in various  Skin diseases and Diarrhoea. 
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    Vilamichu (Plectranthus vettiveroides) 
Vernacular name 
Eng name      :  White  Cuscus grass 
Mal.name      :   Iru veli 
Sans.name     :   Hroeveram    
Part used       :     Ver 
Properties 
Suvai             : Kaiippu 
Thanmai       : Seetham 
Pirivu            :  Inippu 
General character 
 “கம ம்விழிகயரிச்சல்வறீிரத்தபித்தகமோடு 
 தோ மதமூர்ச்மசபித்தந்தன்மயக் ம்- கசோ ஞ் 
 சிரக ோய்இமவகயகுஞ்கசய்யவிலோமிச்சுக் 
 க ரிசுரமும்இல்மலயிமச”. 
    - குணபோடம் மூலிம  வகுப்பு 
Actions 
 Refrigerant 
 Anti-pitta 
Uses 
         It is used in the treatment of Hypertension, Diabetes, Anaemia, Head ache. 
  Atimaduram  (Glycyrrhiza glabra) 
Alternative names  :  Athingam, atti madhugam, Kundri ver. 
Vernacular names 
  Eng name    : Jequitity, Indian or Jamaica liquorice 
  Tel name     : Ati-madhukam, yeati-madhukam   
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  Mal name    : Ati-madhuram, iratti-madhurarr 
  San name     : Yesti-madhukam 
  Hindi name  : Jathi-madh, mulath 
Part  used : Root 
Properties 
  Suvai       : Sweet 
  Thanmai : Hot 
  Pirivu       : Sweet 
Actions   
 Emollient  
  Demulcent 
  Expectorant 
  Tonic 
 Laxative 
General character 
   “                         
                                   
                               
                             
                            
                             
                              
                                 ”. 
        -                  
Uses 
The root of Indian liquorice is chewed for cough. 
It is also indicated for Jaundice, Arthritis, Eye diseases, Skin diseases, 
Leucoderma  and  Migraine. 
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     Muthakkasu  (Cyperus rotandus) 
Other name    : Muthakkasu  
Vernacular names  
  Eng name :   Nut grass    
  San name :   Mutha 
  Tel name :   Tungamusta    
  Hindi name :   Mutha 
  Mal name :   Muththana    
Part used: Root tuber 
Action 
 Astringent 
 Stimulant 
 Tonic 
 Diuretic 
 Diaphoretic 
 Demulcent 
General character 
   “                              
                        -         
                             
                    !   ” 
 
    “                    ஐ   
                        –         
                                         
                       ”. 
-                  
Uses 
The decoction of nut grass is potentially used for fever. 
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It  along with ginger is effectively used to treat dysentery. 
The paste of fresh nut grass is used as an external application for skin rashes. 
It is also an antidote for Indian hemp, opium poisons. 
    
   Vilva poo  (Aegle marmelos) 
Alternative names 
Kushavi, Koovilam, Koovilai, Sivathurumam, Maaluram. 
Vernacular name 
Eng name      :        Bael(tree) Holy fruit tree 
Tel. name      :        Bilvamu 
Mal.name      :         Kuvalam 
Sans.name     :         Bilva    
Hindi name   :        Bel 
Part used    :  Leaves,  Flower, Fruit, Young fruit, Root, Bark, Root bark. 
Properties 
Suvai            : Thuvarppu, Kaippu 
Thanmai      : Thatppam 
Pirivu           :  Karppu 
General character 
                                              
                              –         
                                        
                            . 
-                
Actions 
 Aphrodisiac 
 Febrifuge 
 Stomachic 
 Astringent 
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Uses 
Its juice is used to make drink and squashes, especially in summer season 
because of its sweet and pleasant nature and also used for increase appetite. 
Its extract oil is used to cure respiratory problems. 
      Yelarisi  (Eletaria cardamom) 
Vernacular names  
  Eng name : Cardamomum seeds  
  Tel name : Elakulu 
  Mal name : Elettari     
  Hindi name : Elachi     
  San name : Ela 
Other names: Angi, Korangam, Thudi 
Part used    :   Seed  
  Taste           :  Acrid 
  Character     :   Hot 
  Division       :   Acrid 
Action: Carminative, Stimulant, Stomachic, Aromatic. 
General character 
      “                       
                               
                           
                       
                         
                       
                           
                  ”. 
     -                  
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Uses 
 Useful in various stomach problems and safely used as carminative in 
convalescence after diarrhoea. Decoction of cardamoms together with their pericarp and 
jaggery to relieve giddiness caused by biliousness. 
     Kothumalli  (Coriandrum  sativum)  
Alternative names: Urrul arisi, Dhaniya 
Vernacular name 
Eng name      :   Coriander seeds 
Tel. name      :    Kotimiri 
Mal.name      :    Kotta-malli 
Sans.name     :    Kustumbari 
Kan name      :    Kottamari-bija 
Hindi name    :    Dhanya 
Part  used :     Leaves, Seeds. 
Properties 
Suvai             : Kaarppu, 
Thanmai       : Seetha veppam 
Pirivu            :  Karppu 
General character 
                                                   
                             –         
                              
                       . 
-                
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Actions 
 Stomachic 
 Carminative 
 Diuretic 
Uses 
The seed extracts are used in cleansing of eye. It is also used in the treatment of 
chronic ulcers, giddiness.The spinach of coriandrum sativum is used in the treatment of 
ageusia, fever and it is aphrodisiac in nature. 
Thiripala  
  Kadukai (Terminalia chebula) 
Alternative names 
Anthan, Abhayan,Amutham, Devi,Divya, Rohini, Abaranam, Aritaki, Varikkai, 
Jeevanathi.  
 Vernacular name 
English       :  Chebulic Myrobalan 
Telugu        :  Karak-kaya 
Malayalam:  Katukkai 
Sanskrit     :  Pathya 
Kannadam:  Anile-Kayi 
Hindi         :  Pilen Hara 
Part  used   :  Leaves, Seeds. 
              Suvai            : Kaarppu, 
 Thanmai        : Seetha veppam 
 Pirivu             :  Karppu 
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General character 
                                                     
                                    -            
                                            
                              . 
-                
 
Actions 
 Stomachic 
 Carminative 
 Diuretic 
 Stimulant 
Uses   
The extracts of Terminalia chebula are used in the treatment of polyuria, 
haemorrhoids, dysentery. Kadukkai pills are used in the treatment of ulcers, respiratory 
diseases, anaemia, dropsy, liver diseases, asthma,  ascites  and  leucorrhoea. 
Nelli vatral (Phyllanthus emblica) 
Alternate names 
  Aamalagam, Aalagam,  Aambal, Amarigam, Thaththari, Thathiri,Korangam.                
Vernacular names  
  Eng name :  Indian gooseberry  
   San name :  Amalaki  
   Tel name :  Usirika 
   Hindi name :  Amlika 
   Mal name :  Nellikay     
   Kan name :  Nellikai 
Part used  : Leaf, Flower, Bark, Root, Seed 
Taste  : Sour, Acrid, Sweet 
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Character : Coolant 
Division : Sweet 
Action  : Astringent, Refrigerant, Laxative, Diuretic 
General character 
    “                           
                       -      
                              
                         ”. 
-                
 Uses 
  The dried fruit of amla is indicated for blood related disorders, mennorrhagia,  
psychotic disorder, nausea, vomiting. 
 Decoction of dried fruit is used for nausea, vomiting, giddiness. 
 Also indicated for the treatment of diarrhoea, dysentery, and leucorrhoea. 
          Thandrikkai  (Terminalia  bellerica) 
Alternative names 
Amutham, Coolithurumam, Thabamari,   Erikatbalam , Boothavasakam,  
Veebethekam 
 Vernacular name: 
Eng name      :        Beleric Myrobalans 
Tel. name      :        Thandra-kaya 
Mal.name      :        Thanni-kai 
Sans.name     :        Vebeethaki 
Kan name      :        Tanri-kayi 
Hindi name    :       Bhairah 
Part  used :     Leaves, Seeds, Fruit. 
Properties 
Suvai              : Thuvarppu 
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Thanmai       : Veppam 
Pirivu            :  Inippu 
General character 
                    “                          
                                 -          
                                        
                                 .” 
-                  
Actions 
 Astringent 
 Expectorant 
 Laxative 
 Tonic 
Uses: It is used in the treatment of Hypertension, cough, leucorrhoea, asthma. 
   Ner pori (Oryza sativa)  
Alternative names:  Thorai, Vai, Virihi, Sennel, Sali, Vari 
 Vernacular name 
Eng name      :        Paddy (The husked rice) 
Tel. name      :        Vari 
Mal.name      :         Nella 
Sans.name     :         Vrihi 
Kan name      :        Bhatha 
Hindi name    :         Chaval    
Part used       :     rice 
Properties 
Suvai              : Inippu 
Thanmai       : Thatppam 
 Pirivu            :  Inippu 
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General character 
                                                
                         -        
                                    
                        . 
                  -               
Actions 
 Nutrient 
 Refrigerant 
 Demulcent 
Uses 
         It is used in the treatment of leucorrhoea, fever, ascites, diarrhoea, ageusia. 
Decoction of nerpori is used in the treatment of giddiness, ulcers .  
 Pericham pazham (Phonex dactilifera)  
  Vernacular name 
Eng name      :      Date palm 
Tel. name      :      Karjuramu 
Mal.name      :      Tenech-cha,Perich-cha 
Sans.name     :      Kharjjuram 
Kan name      :      Kharjura 
Hindi name    :     Kajur 
Part used :  Seeds, Fruit. 
Properties 
Suvai              : Inippu 
Thanmai       : Veppam 
Pirivu            :  Karppu 
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General character 
                                       
                        -      
                                
                        . 
-               . 
Actions 
 Tonic 
 Aphrodisiac 
 Nutritive 
 Expectorant 
 Laxative 
 Diuretic 
 Stomachic 
Uses 
         It is used in the treatment of cardiac diseases, scabies, tinea, Hanson’s disease  
cough, diabetes, anaemia, dropsy and  hypertension .  
Patchai karpooram (Borneo camphor)
[10] 
Borneo camphor is one of the twenty five types of Karasaara. 
Vernacular name: Imavalugam, Athaliuppu, Kelithipachchai, Sasi, Chandran,, 
Somanuppu, Seethalam, Pachchai Karpooram, Mathi, Paarmagan Saari,Maruvaali, 
Pooram ,Vintham,Iravikanji And Pachchai Ganasaram.  
It is soluble in atmospheric air. It has pleasant odour, cooling agent. It is considered that 
there are three types of Borneo camphor. 
1. Esan 2.Veeram   3.Poothachirayan. 
General Properties of Esan camphor 
   This is effective in kapha fever, pitha, giddiness and diseases of 
the nose and polydipsia. It is white in colour and sour in taste. 
   “                               
                      -      
                                
                .” 
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General Properties of Veeman camphor 
   This is demulcent and a tonic. It is effective in glossitis, 
polydipsia and vomiting. 
   “                              
                       -      
                              
                   .” 
General properties of Poothasirayan camphor 
   This is effective in controlling of cough, vatha, pitha, kapha 
dosas, three humours, itching and ulcers. If it  is added as an adjuvant with the 
medicines intended for women, it will give best result. 
General properties and uses of Borneo camphor : The borneo camphor is effective in 
eight types of Gastric ulcers, Vatha disease , joint pains and Kapha. 
   “                          
                        -       
                              
                      .”   
This has astringent and salty taste. It’s potency is cold and has expectorant tonic and 
demulcent properties.  
Dosage: 8 mg to 162 mg. 
 Karkandu (Saccharum officinarum) 
Alternative names 
Punarpoosam, ikku, vaei 
Vernacular names   
Eng name : sugar cane, noble cane 
Tel name : cheruku, kanupula-cheruku 
Mal name : karinpa 
Kan name : khabbu 
Sans name : Ikshu, Rasalah 
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Hind name : Ukh-ganna 
Part used    : Juice, Sugar, Root 
Suvai           : Inippu  
Thanmai     : Seetham 
Pirivu          : Inippu 
General properties 
                         
                   –        
                                          
                   . 
-               
 
Actions 
 Demulcent 
 Antiseptic 
 Laxative 
 Diuretic 
Uses:  It is used in the treatment of diabetes, leucorrhea,  male infertility. 
Lavanga pathiri (Cinnamomum tamla) 
Alternative names: Talisapathiri, Tamalapathiri 
 Vernacular name 
Eng name    :    Cassia cinnamon, Indian cassia lignea 
Tel. name    :     Adavi-lavangapatri, Talisapatri 
Mal.name    :    Paccila 
Sans.name   :    Tamalapatram 
Kan name    :    Kadu lavanga patte 
Hindi name  :    Tejpatt 
Part used       :     Leaves 
Properties 
Suvai            : Karppu 
Thanmai      : Veppam 
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Pirivu           :  Karppu 
General character 
                                                     
                                   -       
                                             
                                      . 
                                        -              . 
 Actions 
 Stimulant 
 Carminative 
 Stomachic 
 Diaphoretic 
Uses: It is used in the treatment of Cough, Thirst, Vomiting and Asthma. 
Chiru nagappu (Mesua nagassarium) 
Alternative names   :  
Nagam, Nagaputpam, Naakaesaram, Kaesaram. 
  Vernacular name: 
Eng name      :        Ceylon lorn wood 
Tel. name      :        Naga-kesara 
Mal.name      :         Nakappuvu 
Sans.name     :         Naga-kesara 
Kan name      :        Naga-kesara 
Hindi name    :         Nag-kesar 
Part  used  :     Leaves, Bud, Seeds, Fruit, Bark. 
Properties: 
Suvai            : Siru kaippu, thuvarppu 
Thanmai      : Thatppam 
Pirivu           :  Karppu 
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General character: 
                                                       
                                 -        
                                             
                               . 
-                  
 Actions: 
 Astringent 
 Carminative 
 Aromatic 
 Acrid 
 Purgative 
Uses: It is used in the treatment of Leucorrhoea, Cough, Diarrhoea. 
Koogai neeru  (Marantu arundinacea) 
 Alternative names:  Arrow root kizhangu, Kuva-maa kizhangu, Kookaik kizhangu 
  Vernacular name: 
Eng name      :       East Indian Arrow root   
Tel. name      :       Ararut-gaddalu 
Mal.name      :       Kuva,kuva-kizhanna          
Kan name      :       Koove-Gedde 
Hindi name    :      Tikhar 
Part used       :     Kizhangu 
Properties: 
Suvai             : Inippu 
Thanmai       : Thatppam 
Pirivu            :  Inippu 
General character: 
                                                           
                                      -       
                                               
                                      . 
-                
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 Actions: 
 Refrigerent 
 Demulcent 
 Nutrient 
Uses:  It is used in the treatment of Cough, Fever, Thirst. 
     
   3.1.2 BOTANICAL ASPECT OF THE INGREDIENTS 
       Vitis vinifera 
Taxonomical classification:  
Kingdom :   Plantae                                     
Order  :   Vitales                            
Family :   Vitaceae 
Genus  :   Vitis 
Species :   vinifera 
Distribution: 
  Cultivated  throughout  India. 
Description:  
  A large, deciduous tendril climber, tendrils leaf-opposed, often bifid; leaves 
simple; flowers small green in leaf-opposed, panicles cymes; fruits bluish black; seeds 
2-4 with a discoidal tubercle on the back. 
Part used  :   ripe fruits (dried), leaves, stems, flowers. 
Chemical constituents: Grapes contain a large amount of sugar (15 to 25%), with  
roughly equal amounts of glucose and fructose and only a trace of sucrose. Vitamin C 
content is low (around 3 mg/100g). The fruits contain tartaric acid and malic acid in 
similar concentrations (around0.5g/100g). The red and black grape pigments are 
anthocyanins. 
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 Properties and uses:The fruits are sweet, refrigerant, laxative, cardio tonic, 
antispasmodic, aphrodisiac, rejuvenating, digestive, nervine tonic expectorant and tonic. 
They are useful in vitiated conditions of pitha and kapha, burning sensation, 
constipation, amentia, haemoptysis, anaemia, haemorrhages, fever, leprosy, skin 
diseases, dyspepsia, cough, asthma, bronchitis,   jaundice and general debility. 
     The leaves are astringent anodyne, diuretic and depurative and are useful in 
scabies, cephalalgia, skin diseases, syphilis, haemorrhoids, splenomegaly and vomiting. 
     The ash of the stems is good for arthralgia, haemorrhoids and orchitis. The 
flowers are expectorant, emmenagogue and haematinic [11]. 
       Zingiber officinale 
Taxonomical classification:                        
Kingdom :   Plantae 
Order  :   Zingiberales 
Family :   Zingiberaceae 
Genus  :   Zingiber 
Species :   officinale 
Distribution: Cultivated throughout India, run wild in some places in the Westernghats.  
Description: A slender, perennial rhizomatous herb; leaves linear, sessile, glabrous; 
flowers yellowish green in oblong, fruits oblong capsules. The rhizomes are white to 
yellowish brown in colour, irregularly branched. 
Part used: rhizomes (raw as well as dry) 
Chemical constituents: Ginger contains gingerols, a-curumene, citral, D-camphene, 
geraniol, zingiberenes, zingerone, phellandrene etc.  
Properties and uses: 
   The raw ginger is acrid, thermogenic, carminative, laxative and 
digestive. It is useful in anorexia, vitiated conditions of vata and kapha, dyspepsia and 
inflammations. 
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   Dry ginger is acrid, thermogenic, appetiser, laxative, stomachic, 
stimulant, and rubefacient, anodyne, aphrodisiac and carminative .It is useful in dropsy, 
otalgia, asthma, cough, diarrhoea, anorexia, nausea, vomiting  and  dyspepsia[11a]. 
      Piper nigrum 
Taxonomical classification:                                 
Kingdom       :   Plantae  
Order            :   Piperales 
Family           :   Piperaceae 
Genus            :   Piper 
Species          :   nigrum 
Distribution: 
  Throughout India, in evergreen  forests up to 1,500 m and also widely 
cultivated. 
Description: 
  A stout glabrous climbing perennial, rooting at the nodes; leaves simple, 
alternate; flowers minute in spikes, usually dioecious; fruits ovoid. Seed berries.  
Part used : fruits 
Chemical constituents:  Piperine – 5 -10 % present  both in white and black pepper 
and contains Piperethine,PiperoleinA&B,feruperine,Dihydroferuperine,Citronellol, 
Cryptone,Piperonal, Camphene, B-Caryophyllene, B-alanine, Pipecolic. 
Properties and uses: The fruits are acrid, bitter, carminative, aphrodisiac, anti periodic,    
deobstruant, stimulant and stomachic. They are useful in arthritis, asthma, fever, cough, 
catarrh, dysentery, flatulence, hiccough, haemorrhoids and dyspepsia [12]. 
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      Piper longum 
Taxonomical classification   
Kingdom       :   Plantae  
Order            :   Piperales 
Family           :   Piperaceae 
Genus            :   Piper 
Species          :   longum 
Distribution: Throughout India, in evergreen forests, often cultivated. 
Description: 
  A slender aromatic climber, rooting at the nodes; leaves alternate; flowers in 
solitary spikes; fruits berries, small, red when ripe.The mature spikes collected and 
dried form the commercial form of pippali.Roots are known as pippalimulam.  
Part used: roots,dried spikes. 
Chemical constituents: It contains volatile oil, Resin, Piperin, piperlongumine, 
Brachyamide A & B, Brachystine, sterols, Glycosides. 
Properties and uses: 
        The roots are bitter, thermogenic, tonic, diuretic, purgative, expectorant, 
anthelmintic, stomachic, digestive and emmenagogue. They are useful in vitiated 
conditions of vata, gout, dyspepsia, stomachalgia and splenopathy. 
   The dried spikes are acrid, stomachic, aphrodisiac, carminative, 
expectorant, tonic, laxative and antiseptic. They are useful in anorexia, dyspepsia, 
asthma, flatulent colic, epilepsy and fever [12a]. 
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      Nymphaea alba 
Taxonomical classification                      
Kingdom :    Plantae 
Order  :   Nymphaeales  
Family :   Nymphaeaceae 
Genus  :   Nymphaea 
Species :   alba 
Distribution: 
A native of Europe and north Africa, found in the lakes of Kashmir and in high 
altitude below 1,800 m. 
Description: A perennial aquatic herb with black rhizomes. Leaves entire, orbicular, 
cordate. Flower floating, solitary,10-13 cm diam. Fruit a spongy berry, ripening under 
water. Seeds punctuate, triate, minute, buried in pulp. 
Part used : Seeds, Flower, Rhizome. 
Chemical constituents: The plant contains nupharine, nymphaein and the cardiac 
glycoside, nymphalin. The presence of  β-sitosterol, gallic acid and myricitrin. 
Therapeutical uses: 
 A decoction of flower is valued as a cardiac tonic in palpitation of heart. 
effective in  combating thirst, diarrhea, burning sensation of the body, fainting, 
vomiting and internal hemorrhage. Decoction of rhizomes is given in diarrhoea, 
alcoholic extract has a mild sedative and spasmolytic action. Seeds are used in 
diabetes[14]. 
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           Vetiveria zizanioides 
Taxonomical classification:                  
Kingdom        :   Plantae   
Order             :   Poales     
Family            :   Poaceae  
Genus             :   Chrysopogon   
Species           :    zizanioides    
Distribution: Throughout India, in the plains and lower hills upto 1,200 m. 
Description:  
  A densely tufted perennial grass, with aromatic roots and rhizomes; leaves 
narrow, linear, erect, sheaths compressed, ligules reduced to a scarious rim,midrib 
slender, lateral nerve close, spikelets grey, green or purplish in a panicle of numerous 
slender racemes,sessile spikelets. 
Part used: Roots 
Chemical constituents: Allokhusiol, Benzoicacid, Cyclocapacamphene,  
Epikhusinol, Eugenol, Isovalencic, Isovalencenol, Khusinol, Vanillin, Vertiselinenol, 
Vetivenic acid, Vetiverol, Zizaene, Zizanol etc.
 
 
Properties and uses: 
   The roots are bitter, sweet, acrid, refrigerant, aromatic, depurative, 
haematinic, expectorant, constipating, febrifuge, antispasmodic and tonic. They are 
useful in vitiated conditions of pitta and vata, burning sensation, ulcers, skin diseases, 
anaemia, nausea, dyspepsia, hiccough, fever, cough, asthma, cardiac debility, hysteria, 
amenorrhoea, helminthiasis, spasmodic affections and general debility[11b]. 
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      Santalum album 
Taxonomical classification:           
Kingdom :     Plantae 
Order  :    Santalales 
Family :    Santalaceae 
Genus  :    Santalum 
Species :    album 
Distribution : 
It is commonly found in comparatively dry regions of  peninsular India from 
Vindhya  mountains southwards, especially in Mysore and Tamilnadu, ascending to an 
altitude of 1200 m. it has also been found in dry districts of  Gujarat, Konkan, Deccan, 
Rajasthan, parts of Uttar Pradesh, Madhya pradhesh and Orissa.  
Description : 
A small medium sized, ever green semi parasitic tree, with slender branches, 
sometimes reaching up to 18 m in height and2.4 m in girth. Bark reddish or grey or 
nearly black, rough with deep vertical cracks  on old trees; leaves glabrous ,thin, 
elliptic-ovate or ovate-lanceolate,1.5-8 cm.x1.6-3.2 cm., some times larger; flowers 
straw – coloured, brownish purple, reddish purple or violet, unscented, in terminal 
,axillary paniculate cymes;  drupe globose or 3 cm diam., purple-black, with hard, 
ribbed endocarp; seeds globose or obovoid. 
Parts used: Heart Wood and oil  
Chemical Constituents: 
Sandalwood oil contains α and β santalol, α and β-santalenes, santenol, 
teresantalol, nor-tricycloeka santalal, exo-norbicycloeka santalal, isovaleraldehyde, 
santanone, teresantalic acid, trans-β-santalol, epi-cis-β-santalol, β-santalol, epi-β-
santalane, cis-lanceol, cis-nuciferol, tropan alkaloids, santalbic acid, palmitc acid, 
oleicacid, betulaic acid, glucose, fructose, sucrose, betulinic acid and L-allohy 
droxyproline (leaves, fruit and seeds); urs-12-en-3β-yl.palmitate and β-sitosterol (bark). 
                                                                                                                             REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM  37 
 
Principles constituents of sandal wood:  
Santalol (up to 90%), fusanol, santene, santalic acid, terestanol, borneol, 
santalone and others. 
Properties and uses 
The heart wood and essential oil yielded from it are bitter, sweet, acrid, cooling, 
blood purifier, intellect promoting, diuretic, expectorant, aromatic, deodorant, 
disinfectant, depurative, aphrodisiac, haemostatic, anodyne, cardiactonic, debility and 
spermatorrhea. It is useful in vitiated conditions of pitta, burning sensation, cephalgia, 
skin diseases, leprosy, foul odour due to hyperhidrosis, cardiac debility, loss of memory, 
cystitis,  menorrhagia, intermittent fever and general debility[11c]. 
      Plectranthus vettiveroides 
Taxonomical classification                            
Kingdom :    Plantae 
Class  :    Magnoliopsida 
Order  :    Lamiales 
Family :    Lamiaceae 
Genus  :    Plectranthus 
Species :    vettiveroides (barbatus) 
Synonyms: 
  Plectranthus barbatus, Plectranthus forskholi, Coleus forskholi 
Distribution:  
  Found wild in dry and barren hills of subtropical Himalayas including Kumaon 
and Nepal ascending to 2700 m and in the decan peninsula, Gujarat, Bihar; cultivated in 
Baroda and Maharastra. 
Description: 
A perinneal plant, branched, aromatic herb,about30-60 cm height with thick 
root; stem-stout, villous with long hairs, ascending leaves, narrowed into petioles, ovate 
or abtuse, cerate villous or hispid, flowers borne in recemes, stout; upper calyx lip 
rounded ovate or abtuse; corolla pale blue; fruits nutlets. 
                                                                                                                             REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM  38 
 
Part used : aerial part of the root. 
Chemical constituents: 
Allylroyleanone,barbatusin,3-β-hydroxy-3-deoxy-barbatusin,coleons E and F, 
Cyclobarbatusin, plectrin, plectrinon A and B, barbatusol, 20-deoxocarnosol, coleol, 
coleonol D,E and F, coleonone, coleosol, deoxycoleonol, β-bisabolene, bornylacetate, 
camphene, α-copaene, β-cymene, 3decanone, β-elemene, cariocal,6-α-hydroxy carnosol. 
Therapeutic uses: 
Aerial part-spasmolytic, root-hypotensive, spasmolytic and given to children in 
constipation; decoction as tonic and in the treatment of worms; grounded root internally 
used to treat eczema and skin disease. forskohlii isolated from the root, is a 
bronchodilator, cardiac tonic in the treatment of congestive heart failure,glaucoma 
therapy, anti-hypertensive, remedy for metastatic conditions  and thrombosis[14a]. 
      Glycyrrhiza glabra 
Taxonomical classification                               
Kingdom :     Plantae 
Class  :     Magnoliopsida 
Order  :     Fabales 
Family :     Fabaceae 
Genus  :     Glycyrrhiza 
Species :     glabra 
Distribution: 
Cultivated in Punjab  and  the  subhimalayas tract.  
Description: 
A tall perennial under shrub about 1m high, leaves compound,l eaflet 4-7 pairs; 
flowers violet in racemes; pods, oblong to linear, flantened. The liquorice of commerce 
in the dried underground stems and roots. 
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Its outer surface is pale, chocolate brown in colour, flexible, fibrous and 
internally has a light yellow colour. It has a characteristic pleasant sweet taste. 
Part  used: Roots. 
Chemical constituents: 
Glycyrrhizin, glycyrrhetic acid, glycyrrhetinic acid, 24-hydroxy glycyrrhetic 
acid, mixture of potassium and calcium salts of glycyrrhizin (glycyrrhizic) acid, glabrin 
A and B, glycyrrhetol, glabrolide, isoglabrolide, formononetin, glabrone, neoliquiritin, 
hispaglabridin A and B; heriniarin, umbellifrone; licoagrodin, glabrol, onocerin, β-
amyrin, stigmasterol, β-sitosterol, glabroisoflavanone A and B, glabrocoumarin, 
glychionide A and B and flavanoides[15]. 
Properties and uses: 
The roots are sweet; refrigerant, emetic, tonic, diuretic, demulcent, mild laxative, 
aphrodisiac, expectorant, emmanagogue, alexipharmic, alterant and intellect promoting. 
They are useful in hyperdipsia, cough, bronchitis, vitiated in conditions of vatha, 
gastralgia, cephalalgia, fever, skin diseases, opthalmopathy. 
 An extract of the root is good for treating gastric ulcers. A decoction of the root 
is a good wash for falling and graying of hair. Externally the root is applied for cuts and 
wounds 
[13]
. 
      Cyperus rotandus 
Taxonomical classification:                            
Kingdom :     Plantae  
Class  :     Liliopsida  
Order  :     Poales  
Family :     Cyperaceae  
Genus  :     Cyperus  
Species :     rotandus 
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Description:  
It is a perennial, stolaniferous, rhizomatus, halophytic sedge. Rhizome many 
slender. Tuber-white, succulent when young, hard and black when mature; stem-leafy at 
base arising from a tuber. Leaf above dark green, with reddish brown sheaths, clustered 
at the base of stem. Inflorescence 3-9 spreading rays bearing tassels of few, large 
spikelet; spikelet 20-40 flowered, red brown to almost black. Fruit shape is oblong 
ovate. 
Chemical Constituents: α-cyperone, β-selinene, cyperene, patchoulenone, sugeonol, 
kobusone, and isokobusone, that may scientifically explain the folk- and alternative-
medicine uses. A sesquiterpene, rotundone, so called because it was originally extracted 
from the tuber of this plant. 
Part used: Tubers 
Medicinal Uses: The root is pungent, acrid, cooling, astringent, appetizer, stomachic, 
anthelmintic and useful in treatment of leprosy, thirst, fever, blood diseases, biliousness, 
dysentery, pruritis, pain, vomiting, epilepsy, ophthalmic, erysipelas etc[13a]. 
      Aegle marmelos 
Taxonomical classification       
Kingdom       :    Plantae    
Order            :    Spanidales  
Family           :    Rutaceae  
Genus            :    Aegle  
Species          :    marmelos 
Distribution: 
  Cultivated throughout  in  India,in dry forests.   
Description: 
  A medium sized armed deciduous tree upto 8.0 m high with 
straight,sharp,axillary thorns and yellowish brown shallowly furrowed corky 
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bark;leaves trifoliate,aromatic, alternate;flowers greenish white,sweet scented,in axillary 
panicles;fruits globose;seeds numerous oblong,compressed. 
Part used: Roots, leaves, fruits 
Chemical constituents: Main chemical components are marmelosin, alloimperatorin, 
marmelide, tannic acid, marmin, umbelliferone, isoimperatorin, marmesin; a number of 
essential oils, fatty acids, beta-sitosterol.
 
 
Properties and uses: The roots are sweet, astringent, bitter and febrifuge.They are 
useful in diarrhoea, dysentery, dyspepsia, stomachalgia,vitiated conditions of vata, 
seminal weakness,vomiting and gastric irritability in infants. 
The leaves are astringent, laxative, febrifuge and expectorant and are useful in 
ophthalmia, deafness, inflammations, diabetes And asthmatic complaints. 
The unripe fruits are bitter, acrid, sour, astringent, digestive and stomachic and are 
useful in diarrhoea, dysentery and stomachalgia. 
The ripe fruits are astringent, sweet, aromatic, cooling, febrifuge and tonic and also 
good for the heart and brain and in dyspepsia[13b]. 
           Elettaria cardamomum 
Taxonomical classification                  
Kingdom :     Plantae 
Order  :     Zingiberales 
Family :     Zingiberaceae           
Genus  :     Elettaria 
Species :     cardamomum 
Description: 
Stem perennial, erect, joined,6-9 feet, enveloped in the sheaths of leaves; leaves 
lanceolate, acuminate, sub-sessile, entire,1-2 feet long; sheaths slightly villous; scapes 
several, flexuose, joined, branched1-2 feet long; flowers alternate, short stalked, solitary 
at each point of the receme; calyx funnel shaped, 3-toothed, inely striated, corolla tube 
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as long as the calyx; limb doubled exterior portion of 3 oblong, concave, nearly equal 
division; inner lip obovate, longer then the exterior division, curled at the marings. 
apex 3- lobed, marked in the centre with purple white stripes; capsule oval, 
somewhat 3-sided,3- celled,3-valved;seeds numerous, angular; flowers pale-greenish 
white. 
Part used: Seeds 
Chemical constituents:  
               α-pinene, β-pinene, sabinene, myecene, a-phyllandrene, limonene;1,8-
cineole,y-terpinene, p-cymene, terpinolene, linalool, linalyl acetate, terpinen-4-oil, α-
terterpineol, α-terpineol acetate, citronellol, nerol, geraniol, methyl eugenol and trans-
nerolidol. 
Medicinal uses: 
As cordial and stimulant the seeds are frequently  used medicinally,but more 
frequently as corrective in conjunction with other medicines. A volatile is produced 
from them by distillation, which has a strong aromatic taste, soluble in alcohol. It loses 
its odour and taste by being kept too long. The natives chew the fruit with betle, and use 
it in decoction for bowel-complaints and to check vomiting in infusion it is given in 
cough. 
   Coriandrum sativum 
Taxonomical classification                                               
Kingdom        :    Plantae               
Order              :    Apiales     
Family :    Apiaceae 
Genus  :    Coriandrum 
Species :    sativum 
Distribution: Cutivated throughout  India. 
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Description: 
  A  glabrous, aromatic, herbaceous annual 30-90 cm in height; leaves 
decompounds, lower ones long-petioled and upper ones short petioled; flower small, 
white or pinkish purple in compound terminal umbels; fruits yellowish brown, globular 
and ribbed, separating into two halves each containing a seed. 
Part used: leaves, fruits 
Chemical constituents: 
   It contains essential oil, tannins, terpenoids,reducing sugars,alkaloids, 
phenolics, flavonoids, fatty acids,sterols and glycosides.It also contained high 
nutritional values including proteins,oils,carbohydrates,fibers and vitamins. 
Properties and uses: 
  The leaves are acrid, astringent, aromatic, analgesic, anti-inflammatory, and 
styptic and are useful in halitosis, pharyngopathy, epistaxis, chronic conjunctivitis, 
hiccough, inflammations and jaundice. 
  The fruits are aromatic, bitter, sweet, acrid, astringent, anti inflammatory, 
diuretic, antipyretic, stimulant, expectorant and are useful in vitiated conditions of pitta, 
cough, bronchitis, vomiting, anorexia, diarrhoea, dysentery, dropsy, intermittent fever, 
gout and giddiness[13c]. 
     Terminalia chebula 
Taxonomical classification                      
Kingdom :     Plantae 
Order  :    Myrtales 
Family :    Combretaceae 
Genus  :    Terminalia 
Species :    chebula 
Distribution: Throughout India, in deciduous forests on dry slopes upto 900 
m,especially in Bengal,Tamilnadu,West coast and Western ghats. 
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Description: 
  A moderate sized to large deciduous tree with a cylindrical bole,rounded crown 
and spreading branches; leaves ovate, elliptic, glabrous to tawny-villous beneath with a 
pair of large glands at the top of the petiole;flowers yellowish white in terminal simple 
spikes;fruits glabrous,shining,ellipsoidal, ovoid drupes, yellow to orange brown in 
colour;seeds hard,pale yellow. 
Part used: mature and immature fruits 
Properties and uses: The fruits are astringent, sweet, acrid, bitter, sour, thermogenic, 
anodyne, anti-inflammatory, vulnerary, stomachic, laxative, purgative, carminative, 
digestive, cardiotonic, diuretic, antiseptic, aphrodisiac and tonic. They are useful in 
vitiated condition of tridosa, wounds, ulcers, inflammation, anorexia, helmenthiasis, 
haemorrhoids, jaundice, hiccough, cough, renal calculi, epilepsy, skin disease, cardiac 
disorder, neuropathy and genral  debility [11d]. 
    Indian gooseberry 
Taxonomical classification                        
Kingdom   :   Plantae 
Class         :   Magnoliopsida  
Order        :   Malpighiales 
Family      :    Phyllanthaceae 
Genus       :    Phyllanthus 
Species     :   emblica 
Distribution: 
A native of India, Wild or cultivated throughout tropical India from the foot of 
the Himalayas. It grows in Kurinji and Marutam tinai. 
Description: 
A large handsome deciduous tree with greenish-grey or red bark: peeling of 
scales and long stripes. Leaves pinnate distichously close set, linear -oblong; Feathery 
                                                                                                                             REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM  45 
 
small leaves are fine and delicate. The tree has a peculiarity of shedding its twigs along 
with the leaves attached; flowers are very small, greenish densely fascicled along the 
branchlets, yellowish; males on slender pedicels, females sub sessile; the flowering 
period is from March to May. 
Parts used: Fruits, seeds, flowers, leaves, barks, roots 
Chemical constituents: It contains Ascorbic acid, Tannins, Phyllemblic acid, Emblicol, 
Gallic and Ellagic acid. 
Medicinal uses: 
Astringent, carminative, stomachic and tonic. Seeds used in eye problems.  
Flowers refrigent; leaves juices applied externally to ulcers; infusion mixed with 
fenugreek seeds useful in chronic dysentery; bark and root astringent [12d]. 
    Terminalia bellirica 
Taxonomical classification                            
Kingdom   :    Plantae    
Order        : Myrtales 
Family       : Combretaceae 
Genus        : Terminalia 
Species      : bellirica 
Distribution: throughout India, in deciduous forests upto an elevation of  900 m. 
Description: 
  A large deciduous buttressed tree,20-30 m in height with thick brownish grey 
bark having shallow longitudinal fissures; leaves simple, alternate, long-petioled, 
crowded about the extremities of the branches, brodly elliptic, margine entire, main 
nerves 6-8 pairs, midrib prominent on both surfaces; flowers pale greenish yellow with 
an offensive odour; fruits ovoid grey drupes. 
Part used: bark, fruits 
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Chemical constituents: 
   Its principal constituents are β-sitosterol, gallic acid, ellagic acid,ethyl 
gallate, galloyl glucose, chebulic acid, glucose, galactose, fructose and raminose. 
Properties and uses: The bark is mildly diuretic and is useful in anaemia and 
leucoderma.The fruits are astringent, acrid, sweet, thermogenic, antiinflammatory, 
anodyne, styptic, narcotic, digestive, anthelmintic, expectorant, antipyretic, antiemetic 
and rejuvenating. They are useful in vitiated conditions of kapha and vata, cough, 
bronchitis, insomnia, dropsy, dyspepsia, vomiting, skin diseases, leprosy, fever and 
general debility. 
 The mature and dry fruit is constipating and is useful in diarrhoea and dysentery. 
The oil obtained from the seeds is trichogenous and is useful in dyspepsia, skin 
diseases, leucoderma and greyness of hair[11e]. 
                         Oryza sativa 
Taxonomical classification :     
Kingdom       :      Plantae     
Order  :     Poales 
Family :     Poaceae  
Genus  :    Oryza  
Species :     sativa 
Distribution: Cultivated throughout in India. 
Description: 
  An annual or perennial grass with tuft of fibrous roots and swollen nodes; leaves 
simple with sheathing bases, long and narrow, slightly pubescent with spiny hairs on the 
margins; flowers spikelet’s in terminal compound panicles, lemma punctate or granulate 
without wing on the back, lemma and palea surrounding the kernel, golden yellow, 
reddish purple, brown or smoky black becoming straw-coloured on ripening, grains 
narrowly oblong, free within the lemma and palea. 
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Part used: Roots, grains 
Chemical constituents:  It contains majority of the tocotrienols and tocopherols (77 
and 73% respectively) and oryzanols (91 %) remain integral to the oil bodies, one 
steroid-based antioxidant, ϒ-oryzanol.  
Properties and uses: The roots are cooling, diuretic and febrifuge; and are useful in 
burning sensation, dipsia, bilious fever, strangury and diabetes. 
The grains are sweet, acrid, oleaginous, aphrodisiac, diuretic, carminative, anti 
dysenteric and tonic. They are useful in vitiated conditions of pitta, pneumonosis 
especially pulmonary consumption, diarrhoea and colonopathy [12e]. 
        Phonex dactilifera 
Taxonomical classification                        
Kingdom        :     Plantae   
Order  :    Arecales 
Family :    Arecaceae 
Genus  :    Phoenix 
Species :    dactylifera 
Distribution: A native of North America, Egypt, and Arabia; Now cultivated in Sindh     
Punjab. 
Description: 
  A tall palm up to 36 m in height, the trunk covered over by persistent petiole 
bases, the base surrounded by a dense mass of root suckers; leaves pinnate up to 5 m 
long, lower pinnae modified into spines; flowers in long spadices, unisexual, fruits 
oblong berries reddish or yellowish brown when ripe, pulp fleshy, sweet; seeds 
cylindric, hard with a longitudinal furrow in front. 
Part used: Leaves, flowers, fruits, seeds 
Chemical constituents: It contains important phyto chemicals including carotenoids, 
phenolics and flavanoids. 
                                                                                                                             REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM  48 
 
 Properties and uses: 
   The leaves are aphrodisiac and are reported to be good for hepatopathy. 
Flowers are bitter, purgative, expectorant, hepatic and febrifuge. 
   Fruits are sweet, cooling, aphrodisiac, tonic and diuretic. They are useful 
in nephropathy, pectoral diseases, bronchitis, cough, burning sensation and gastropathy. 
   A paste made out of the seeds is good for the opacity of the cornea, 
cephalalgia inflammations and wounds.The toddy is aphrodisiac, digestive, appetising, 
intoxicating and tonic. It is useful in bronchitis and vitiated conditions of vata and 
kapha[12f]. 
      Saccharum officinarum 
Taxonomical classification :                 
Kingdom :    Plantae 
Order  :    Poales 
Family :    Poaceae 
Genus  :    Saccharum 
Species :   officinarum 
Distribution:  Cultivated  throughout  in India. 
Description:  
A tall perennial grass, upto 6 m high with stems of varying thickness and colour; 
leaves 1.5 m long,60 cm broad, erect or drooping, varying in colour from light to dark 
green; in florescence large, pyramidal, spikelets usually surrounded by long silky hair 
from their base, glumes two, glabrous on the back, grains oblong to sub globose. 
Part used : Roots, Stems. 
Properties and uses: The roots are cooling and diuretic and are useful in uropathy. 
The stems (sugarcane) are sweet, cooling, emollient, laxative, cardio tonic, 
diuretic, galactogogue, aphrodisiac, expectorant, haemostatic and tonic. They are useful 
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in fatigue, leprosy, gastropathy, cardiac debility, haematemisis, cough, bronchitis, 
anaemia, erysipelas, ulcers of the skin and mucus membrane, emaciation and general 
debility
[11f]. 
    Cinnamomum tamala 
Taxonomical classification                      
Kingdom        :      Plantae    
Family            :      Lauraceae 
Genus             :      Cinnamomum 
Species           :       tamala 
Distribution: Himalayas in areas of 900-2,400 m elevation 
Description:        
  A moderate sized evergreen tree 7.5m in height with dark brown or blackish; 
leaves simple, opposite; ovate-lanceolate or ovate-oblong; flowers pale yellowish in 
axillary and terminal, lax puberulous panicles; fruits ovoid, fleshy, black drupe, 
supported by enlarged perianth tube. 
Part used: Leaves 
Chemical constituents: 
        The leaves yield an essential oil, which contains eugenol and 
phellandrene. The essential oil from the bark contains aldehyde.
 
 
Properties and uses: 
    The leaves are bitter, sweet, aromatic, and thermogenic,    anthelmintic, 
diuretic, stimulant, carminative and tonic. They are useful in cardiac disorders, 
inflammations, helminthiasis, dyspepsia, vitiated conditions of vata, diarrhoea and 
splenopathy[13d]. 
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     Mesua nagassarium 
 Taxonomical classification                      
Kingdom :      Plantae  
Order  :      Malpighiales 
Family :      Clusiaceae 
Genus  :      Mesua 
Species :      ferrea 
Distribution: Throughout India, in evergreen forests up to 1,500 m.  
Description: A medium sized to large handsome, glabrous, evergreen tree,18-30 m in 
height and reddish brown bark which peels off in thin flakes; leaves simple, opposite, 
thick, covered with waxy bloom underneath, acute or acuminate nerves; flowers white,  
fragrant, axillary or terminal, stamens very numerous, golden yellow, much shorter than 
the petals; fruits ovoid with a conical point surrounded by the enlarged  sepals; seeds 1-
4,angular,dark brown, smooth. 
Part used: Flowers, oil 
Chemical constituents: It contains mensuol, sitosterol, fatty acids, cyclohaxodine, 
mesuanic acid α- and β AMYRIN. 
Properties and uses: 
   The flowers are astringent, bitter, acrid, anodyne, digestive, carminative, 
anthelmintic, diuretic, expectorant, stomachic, aphrodisiac and cardio tonic. They are 
useful in vitiated conditions of pitta and vata, asthma, cough, vomiting, scabies, leprosy, 
pruritus, ulcers fever and cardiac debility[12g]. 
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      Maranta arundinacea 
Taxonomical classification :           
Kingdom: Plantae 
Order:  Zingiberales  
Family: Marantaceae 
Genus:  Maranta 
Species: arundinacea 
Distribution: Cultivated throughout India 
Description: 
  A erect slender branched herb,90-180 cm high with fleshy cylindrical obovoid 
rhizome covered with pale scales leaving scars on falling; leaves ovate-oblong to ovate-
lanceolate, base rounded; flowers white in clusters on diverging inflorescence branches, 
fertile stamen with appendage, ovary one-celled, one-ovuled.  
Part used : underground rhizome.  
Chemical constituents: 
 Maranta arundinacea tubers contain about 25-30% neutral starch, fiber, fat, 
albumen, sugar and gum. They are dried and powdered to get a white-starchy powder 
known as Arrowroot. This plant is different from Indian Arrowroot. 
Properties and uses: 
 Starch obtained from rhizome is astringent, sweet, refrigerant, tonic, aphrodisiac, 
emollient, expectorant and febrifuge. It is useful in dysentery, diarrhoea, dyspepsia, 
bronchitis, cough and also as a nourishing food for infants, invalid and convalescents. It 
is the main ingredient in biscuits, cakes, puddings, jellies and face powders [12h].   
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      3.2 DISEASE REVIEW 
      3.2.1 SIDDHA ASPECT  
      RAKTHA AZHUTHAM 
Definition: It refers to the functional divergence in seneer thathu (blood), produced as a 
results of increased azhal (bio energy fire) eventully leading to consequent functional 
dearrangements in other udal thathus. 
Vernacular names: 
 “இரத்தவ முக்கத்தியர் பெயரு ரரத்திடிற் 
  இரத்தாதிக்கம் யழுத்தம் இரத்தக் பகாதிப்பு 
  நந்திடும் நாடி இறுக்கமும் நவில்வரீ் 
  ெத்திடுங் காரணம் ெகரக் ககண்க ா” 
      -                        [16] 
Raktha soodu, raktha azhutham, raktha miguthi, raktha perukkam, rakthathikkam, 
narambirukkam  and  naadi irukkam. 
Types of Raktha Azhutham: 
 Vali kuruthi azhal noai 
 Azhal kuruthi azhal noi 
 Iyya kuruthi azhal noai 
 Vali thee kuruthi azhal noai 
 Vali iyya kuruthi azhal noai 
 Iyya vali kuruthi azhal noai 
 Iyya azhal kuruthi azhal noai 
 Mukkutra kuruthi azhal noai 
Clinical features: 
 Initially it begins with reccurent cough. 
  Vomiting, Indigestion, fever will be a associated symptoms 
 Head ache most commonly seen in occipital region. 
                                                                                                                             REVIEW OF LITERATURE 
 
ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM  53 
 
  Dizziness, palpitation, easy fatigability, weakness. 
  Dysponea, chest pain, pallor 
  Perspiration, vertigo, syncope. 
 Epistaxis, heamaturia, blurring of vision. 
 Bloody vomiting will be common 
 Sometimes bleeding will be seen in eyes, ears, nose, skin etc.. 
Clinical features: 
 Head ache most commonly seen in occipital region, dizziness, 
palpitation, easy fatigability, weakness. 
 Dyspnoea, chest pain, pallor, perspiration, vertigo, syncope. 
 Epistaxis, heamaturia, blurring of vision. 
Kuruthi azhal noi is high in urban population and more common in men than 
women. In females the prevalence is closely related to age. This is increased 
presumeably related to the menopause. 
  The  Elavenil (early summer),Muthuvenil (late summer) aggrevate the disease. 
Paalai (arid-tract) and Neithal (coastal-tract) reported compared to other areas. 
3.2.2 MODERN ASPECT OF THE DISEASE 
HYPERTENSION 
The history of hypertension starts with the understanding of the cardio vascular 
system with the work of physician William Harvey who described the circulation of 
blood in his book “De motu cordis”. Then the English clergyman Stephen Hales is 
generally credited as being the first person to measure arterial pressure, direct intra-
arterial pressure in the horse in 1733. Hypertension was described as a disease by 
Thomas young and Richard in 1836. In 1884 the first report of elevated blood pressure 
in a person without evidence of kidney disease was recorded. Eventually in 1896 the 
invention cuff-based sphygmomanometer done by Scipione Riva-Rocci. Then the blood 
pressure was measured in the clinics, Nikolai Korotkoff improved this technique by 
describing the Korotkoff sounds. These sounds are heard when the artery was 
auscultated with a stethoscope while the sphygmomanometer cuff was deflated. 
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Now in modern medicine hypertension is classified into two types essential and 
secondary hypertension. The concept of essential hypertension was introduced in1925 
by the physiologist Otto frank, which has idiopathic origin. In 1928 the term malignant 
hypertension was coined by physicians from the mayo clinic. The essential hypertension 
may be the result of a combination of poor life style choices and genetics. Secondary 
hypertension that starts as a result of another disease especially kidney disease or 
disease associated with endocrine system
[17]
. 
Definition: 
Systemic hypertension is the persistent rise of basal blood pressure above the 
level of 140/90 mm of Hg recorded on three or more successive occasions [18]. 
Classification of hypertension [19] 
Etiological classification: 
 Essential hypertension or idiopathic hypertension 
 Secondary hypertension or symptomatic hypertension 
Benign hypertension 
 BP is more than 140/90 mmhg but less than 200/140 mmhg 
 Progresses slowly 
Malignant hypertension 
  BP rises rapidly 
 BP > 200/140 mmhg 
 Shows retinal changes 
White coat Hypertension 
Commonly known as white coat syndrome or masked hypertension, is a 
phenomenon in which patients exhibit a blood pressure level above the normal range, in 
a clinical setting, though they don’t having exhibit other it in other settings. It is 
believed that the phenomenon is due to anxiety that those afflicted experience during a 
clinica visit 
[20]
. 
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Pathophysiology of Hypertension 
Blood pressure is determined by the balance between cardiac output and 
vascular resistance rise in either of these variables, in the absence of a compensatory 
decrease in the other, increases mean BP, which is the driving pressure. 
Table no:1 Classification of blood pressure for adult(JNC7)
[21]
 
Category Systolic mmHg Diastolic mmHg 
Normal 90-119 60-79 
High normal 
(pre-hypertension) 
120-139 80-89 
Stage I 
Hypertension 
140-159 90-99 
Stage II 
(Hypertension) 
160-179 100-109 
Stage III 
(Hypertensive emergency) 
≥ 180 ≥ 110 
Isolated Hypertension ≥ 140 < 90 
 
Factors that affect cardiac output include the following 
 Barorecptors 
 Extracellular volume 
 Effective circulating  volume- Arterial natriuretic hormones, 
mineralocorticoids, angiotensin 
 Sympathetic nervous syndrome 
Factors that affect vascular resistance include the following: 
 Pressors :angiotensinII,calcium(intracellular),catecholamines,vasopressin 
 Depressors :Artial natriuretic hormones, endothelial relaxing factors, 
kinins, prostaglandin, prostaglandin E2, prostaglandin I2 
Changes in the electrolyte homeostasis particularly in sodium, calcium and 
potassium concentrations, affect some of these factors. 
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Under normal conditions, the amount of sodium excreted in the urine matches 
the amount of ingested, resulting in near constancy of extracellular volume. Retention 
of sodium results in increased extracellular volume, which is associated with elevation 
of Bp. By means of various physical and hormonal mechanisms, this elevation triggers 
changes in both the glomerular filtration rate (GFR) and the tubular reabsorption of 
sodium,resulting in excretion of excess sodium and restoration of sodium balance. 
Increase in the intracellular calcium concentration,due to changes in plasma 
calcium concentration,increases vascular contractility. In addition, calcium stimulates 
release of rennin, synthesis of epinephrine and sympathetic nervous system activity. 
Increased potassium intake suppresses the production and release of rennin and induces 
natriuresis, decreasing the Bp. 
Table no: 2 Common causes of hypertension by age 
               Infants               Children 
     1-6 yrs 
              Children 
      7-12 
Thrombosis of renal artery 
or vein 
Renal artery stenosis Renal parenchymal disease 
Congenital renal anomalies Renal parenchymal disease Renovascular abnormalities 
Coarctation of aorta Wilms tumor 
Neuroblastoma 
Endocrine causes 
Bronchopulmonary 
dysplasia 
Coarctation of aorta Essential hypertension 
 
Predisposing factors for essential hypertension 
 Family history 
 Genetic factor-homozygos or the dominant gene is usually seen to be severly 
affected than the heterozygous. 
 Age-commonly 45 years. But varies from 25 to 55 years. 
 Sex-commonly seen in males 
 Structural changes in arterioles: Thickening of the arteriolar wall and 
narrowing of the lumen leads to resistance in the blood flow. 
 Salt intake: If the salt intake is more than the average, hypertension may 
result. 
 Race - common in American Negroes and Japanese 
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 Influence of the sympathetic nervous system: Excessive sympathetic nervous 
activities may result in hypertension. It has an important role in young 
hypertensives who usually exhibit tachycardia and high output. 
 Neurogenic hypertension-lesion of the carotid sinus and aortic baroreceptor 
may lead to hypertension. 
 Psychic factor-it act  via neural pathway 
 Rennin Angiotensin system-renin is secrered from the juxta glomerular cells 
surrounding the afferent arteriole from various stimuli,e.g diminished renal 
perfusion, diminished blood volume, diminished cataecholamines, increased 
sympathetic activity, arteriolar stretching, hypokalaemia, etc.renin acts on 
angiotensinogen or rennin substrate to convert it to Angiotensin I. This is 
acted upon by Angiotensin II. This is a potent vasoconstrictor  and  
stimulates aldosterone release from adrenal gland. Though the system has an 
important bearing on regulating blood pressure yet possibly it has no primary 
role in the pathogenesis of essential hypertension. 
 Defect in natriuresis: In presence of elevated blood pressure, high serum 
Na+ or blood volume individual have increased natriuresis. In hypertensives 
this Na+ excretion ability is diminished, so this results in increased blood 
volume and high BP. 
 In essential hypertension intracellular Na and Ca  are elevated 
 Miscellanious: Excessive intake of alcohol, smoking, steroids and NSAIDs, 
low potassium intake, exercise, polycythemia etc. 
Causes for secondary hypertension 
 Renal causes-acute nephritic syndrome, Chronic nephritis, Poly cystic 
kidney, Hydronephrosis, Chronic pyelonephritis, Renal artery stenosis, 
Rennin secreting tumour, Renal embolism. 
 Endocrine causes-thyrotoxicosis and myxoedema, acromegaly, 
Cushing’s syndrome, Cohn’s syndrome, phaeochromacytoma. 
 Metabolic causes- diabetes mellitus, chronic gout, toxaemias of 
pregnancy, atherosclerosis. 
 Drugs- contraceptive pills, anabolic steroids, liquorice. 
 Collagenosis and miscellaneous disease- SLE, polyarteritisnodosa 
scleroderma, dermatomyositis, pseudoxanthoma elasticum. 
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 Congenital- coarctation of aorta. 
 Psychogenic 
 Neurological- encephalitis, brain tumour, cerebro vascular accident, 
diencephalic Syndrome. 
 Blood disease- Polycythemia 
 Renovascular hypertension-particularly in renal artery stenosis. 
 Miscellaneous- Pregnancy, Cyclosporine, NSAIDs.[22] 
Clinical features: 
 Pulsating head ache often occipital and occurs particularly in the 
morning. 
 Easy fatiguability 
 Insomnia 
 Dizziness 
 Lack of concentration 
 Loss of memory 
 Occational palpitation 
 Breathlessness 
Symptoms of associated disease may also present e.g. Cerebral Arteriosclerosis, 
Retinal Arteriosclerosis, Coronary Arteriosclerosis, Renal arteriosclerosis and 
Arteriosclerosis of limb of vessel [23]. 
Complication: 
Cardiac hypertensive heart disease Left Ventricular Hypertrophy develops in 10-30% 
of chronic cases. It may produce myocardial ischemia, ventricular arrhythmia, CCF and 
sudden death LV diastolic dysfunction may also develop with CCF. 
Cerebral 
Cerebro vascular complications are more closely to systolic rather than diastolic 
blood pressure. 
 Cerebral hemorrhages 
 Cerebral thrombosis 
 Lacunars infract 
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 Hypertensive encephalopathy-this condition is acute cerebral ischemia 
from Hypertensive spasm, Cerebral edema and minor degree of 
hemorrhages or thrombosis. 
 TIA-transient ischemic attack 
 Subarachnoid hemorrhages. 
 Dementia-both vascular and Alzheimer’s type 
Retinal  
 Dimness of vision 
 Thickening of arteries with Narrowing of lumen, Hemorrhages and 
Exudates. 
 Papilloedema. 
 Detachment of Retina, Vitreous Hemorrhages. 
Renal 
Patients with hypertensive nephropathy should have BP at 130/85mmHg or less 
if protenuria is present. Hypertension accelerates all forms of renal disease mostly 
diabetic nephropathy. 
 Nephrosclerosis 
 Uraemia 
 Renal infarct 
Aortic dissection 
 The major cause of  it  is hypertension. 
Atherosclerotic complications Many patients of hypertension die out of these 
complication but the relationship is much less close than other complications. 
 Cerebral arteriosclerosis 
 Retinal arteriosclerosis 
 Coronary arteriosclerosis 
 Renal arteriosclerosis 
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Pregnancy induced hypertension 
Gestational hypertension also referred to pregnancy induced hypertension (PIH) 
it is a condition of high blood pressure more than 140/90mmHg on two separate 
occasions, more than 6 hours apart, without the presence of protein in the urine during 
pregnancy. It is diagnosed after 20 weeks of gestation. Gestational hypertension can 
leads to serious condition called pre-eclampsia 
[24]
. 
Hypertensive crisis 
   In some situations in an hypertensive patients rapid reduction of blood pressure 
is required. These situations are included under the category of hypertensive crisis. 
These situations  are  divided into two. 
Hypertensive urgency 
  There is no evidence of end organ damage resulting from the elevated blood 
pressure.In these cases, oral medications are used to lower the BP gradually over 24 to 
48 hours. 
Hypertensive emergency (Malignant hypertension)  
There is evidence of direct damage to one or more organs.The most affected 
organs include the brain, kidney, heart and lungs, producing symptoms which may 
include confusion, drowsiness, chest pain and breathlessness.In hypertensive 
emergency,the blood pressure must be reduced more rapidly to stop ongoing organ 
damage. 
Clinical features include  
 Headache 
 Confusion 
 Visual loss 
 Focal Neuralogic features 
 Somnolence 
 Coma 
 Fundus shows Hemorrhages, Exudates and Papilloedema. 
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Mode of termination 
 Acute left ventricular failure(60%) 
 Cerebral hemorrhages (35%) 
 Uraemia rare(5%) 
Investigations 
Patients undergo a limited number of investigations 
Investigation of all patient 
 Urinanalysis for Blood, Protein and Glucose 
 Blood, Urea, Electrolytes and creatinine 
 Lipid profile 
 Blood glucose 
 Serum total and high-density lipoprotein(HDL) Cholesterol 
 12-lead ECG(left ventricular Hypertrophy, Coronary artery disease) 
 Endocrine: Serum Sodium, Potassium, Calcium and TSH[25] 
Investigation of selected patient 
 Chest X-ray: To be detect Cardiomegaly, Heart failure, Coarctation of 
aorta 
 Ambulatory BP recording: To assess borderline hypertension 
 Echocardiogram: To detect or quantify left ventricular hypertrophy 
 Renal Ultrasound: To detect possible renal disease 
 Renal Aangiograpy: To detect or confirm presence of renal artery 
stenosis 
 Urinary Catecholamines: To detect possible Pheochromacytoma 
 Urinary Cortisol and Dexamethasone suppression test: To detect possible 
Cushing’s  Syndrome. 
 Plasma Rennin Activity and aldosterone: To detect possible primary 
aldosteronism
[26]. 
DRUG REVIEW –TREATMENT FOR HYPERTENSION IN SIDDHA ASPECT 
In siddha system the treatment for raktha pittha is based on the normalizing the  
altered  hypertension. 
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Vanthi and kazhichal maruthuvam 
 Vellai ennai-15-30 ml at early morning 
 Meganatha thylam-8-30ml at early  morning 
 Kowshikar kuzhambu-125-500 mg with ghee at early morning 
 Thiratchai kudineer-40-80ml twice a day 
 Nerunjil kudineer-40-80ml twice a day 
 Thamaraga kudineer-40-80ml twice a day 
The choices of medicine, doses and duration may be altered according to the 
condition of the patients and severity of the disease. 
Chooranam 
 Seenthil chooranam-1-2g twice a day with ghee(5ml) 
 Elathy chooranam1-2g twice a day with warm water(50ml) 
 Parangipattai chooranam:1-2 g twice a day with hot water(50ml) 
 Seeraha chooranam-1-2 g twice a day with hotwater(50ml) 
 Thrachathy chooranam-1-2g twice a day with honey(5ml) 
 Venthamarai chooranam-1-2g twice a day with hotwater(50ml) 
 Marutham pattai chooranam-1-2 g twice a day with hotwater(50ml) 
 Amukkara chooranam1-2g twice a day with milk(50ml) 
Nei 
 Brahmi nei10-15ml twice a day with milk(50ml) 
 Madhulai nei 10-15ml twice a day with milk(50ml) 
 Thaneer vitan nei 10-15ml twice a day with milk(50ml) 
Manappagu 
    Thurunchi manappagu15ml twice a day with luke warm water (50ml) 
   Nannari manappagu15ml twice a day with luke warm water (50ml) 
  Madhulai manappagu 10-15 ml twice a day with luke warm water(50ml) 
Ilagam 
  Vilvathy ilagam5-10g twice a day 
  Madhulai manappagu 3g twice a day 
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Karpam  
 Bavana kadukkai(500mg) 1 before and after food twice day 
Parpam 
 Silasathu parpam300-600mgtwice a day with hot water(50ml) 
 Kungiliya parpam100-300mg twice a day tender coconut water(50ml) 
 Sangu parpam100-300mg twice a day with ghee(5ml) 
 Muthu parpam65-130mg twice a day with ghee(5ml) 
 Siringi parpam65-130mgtwice a day with brahmi nei(10ml) 
Chendooram  
 Vediannabethi chenduram100-200mg twice a day with honey(5ml) 
 Aya chenduram65-130mg twice a day with honey(5ml) 
In higher levels if palpitation and dysponea present than use 
 Pavala parpam 100-200mg twice a day with ghee(5ml) 
 Muthu parpam30-60mg twice a day with honey(5ml) 
 Naga parpam65-130mg twice a day with honey(5ml) 
External medicines 
Oil bath may be adviced  twice  a week with any of the following medicated oil 
 Kaiyan thylam 
 Seeraha thylam 
 Lahusandhanathy thylam 
 Arakku thylam 
 Thirippala thyalm 
Pathiyam(diet) 
Diet to be added 
 Rice kanji-double boiled rice, savarisi kanji, pori kanji, barley kanji, 
manakkathai,kuruvai rice. 
 Vegetables-athi, avarai, kathari, vazhai, vendai, murungai, sundai, mullongi, 
pagal, sambal poosani, thoothuvalai, pirandai. 
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 Greens-puliyarai, manathakkali, ponnangani, kaiyan, sukkan, vasalai keerai, 
pasalai keerai. 
 Pulses-ulunthu, pasipayaru 
 Dairy products-cow’s butter milk 
 Non-vegetrarian diet-ayrai meen(loach), velladu(capea hircus) 
Diet to be avoided  
 Intake of excessive salt,oil,fried food 
 Excessive hot,sour and salt tastes, 
 Sarkkarai valli kizhangu (Ipomoea batatas), Seppankizhangu 
(Colacasiaesculanta), Kothavarai (Cyamopsis tetragonoloba), Kollu 
(Macrotylorum uvifiorum), Verkadalai (Arachis hypogea), Kaaramani (Vigna 
ungiculata), Pataani (Pisum sativum), Motchai(lablab purpureus)[27]. 
Other advices 
 Avoid smoking and alcohol intake 
 Dietary management  
 Regular physical activity(brisk walking) at least 30 min/day 
 Weight reduction, maintain normal body weight 
 Relief of stress. 
 Rejuvenation therapy  
Karpa marunthugal 
Pothu karpam 
 Kattrazhai karpam for 4 days 
 Ponnangani karpam for 4 days  
Sirappu karpam 
 Kadukkai karpam1-2gms with hotwater at evening for 48 days 
 Panai ver kudinner 60ml twice a day for 48 days 
 Vilva karpam for 48 days 
 Elumitchai pazha karpam for 48 days 
 Orilai thamarai karpam with ghee for 48 days. 
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Karpayogam 
 Pranayamam 
 Singasanam 
 Sarvangasanam 
 Puyangasanam. 
TREATMENT FOR HYPERTENSION IN MODERN ASPECT[28] 
Anti-hypertensive drugs act by influencing the Blood pressure regulatory 
systems viz, the autonomic nervous system, Rennin Angoitensin System. Calcium 
channels or sodium and water balance in plasma volume. 
Classification of anti-hypertensive drugs  
Diuretics  lowers the blood pressure by increasing urination.the anti hypertensive action 
of diuretics is mild BP falls by 15-20mmHg over 2-4 weeks. It enhance the excretion of 
sodium and water resulting in decreased plasma volume of CO and reduce BP. 
 Thiazides(Hydrochlorothiazide,Chlorothiazide,Indapamide) 
 Loop diuretics(Fruosemide,Bumetanide,Torsemide) 
 K+ (Spiranolactone,Amiloride,Trimterene) 
Drugs acts on Rennin Angiotensin System 
 Angiotensin converting enzyme inhibitors(ACE inhibitors) (Captopril, 
Enalapril, Lisinopril, Ramipril, Perindopril) 
 Angiotensin II receptor antagonists (Losartan, Candesartan, Valsartan, 
Eprosartan, Irbesartan,Olmesartan) 
 Rennin inhibitor(Aliskien) 
 ACE inhibitors are presently the first line anti hypertensives.ACE inhibitors 
are useful in the treatment hypertension of all grades due to all causes. They 
are specially indicated as Anti-hypertensives in hypertension with left 
ventricular hypertrophy. 
 Angiotensin II is powerful vasoconstrictor.ARBs are used in the treatment of 
hypertension in similar indications as that of ACE inhibitors as alternatives 
of ACE inhibitors, they can also be considered as the first line drug in 
hypertension. 
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 Rennin inhibitors blocks the effects of rennin there by reducing blood 
pressure. Use of several drugs like ACE inhibitors, ARBs and diuretics tend 
to bring about a compensatory rise in the plasma rennin levels. Because  
aliskiren blocks the effects of rennin,its action is synergistic with these 
drugs. 
Sympatholytics 
 Centrally acting drugs(Clodine,Methyldopa,Guanfacine) 
 Ganglion blockers(Trimethaphan) 
 Adrenergic receptor blockers(Guanethidine,Reserpine) 
 Adrenergic receptor blockers 
 α-blockers (Prazosin, Terazosin, Doxazosin, Phenoxybenzamine, 
Phentolamine) 
 β-blockers (Propranolol, Atenolol, metoprolol) 
 α and β blockers(Labetalo,Carvedilol). 
Sympatholytics drugs may be used to interfere with sympathetic activity at 
different levels including centrally,at the ganglia,neurons and receptors. 
Ganglion blockers block both sympathetic and parasympathetic ganglia resulting 
in decreased sympathetic tone and a fall in BP. 
Adrenergic receptor blockers depletes the stores of nor adrenaline in the 
adrenergic neurons blockers its release. 
α-blockers are used in the treatment of hypertension due to Pheochromacytoma. 
They block the α1 receptors in the arterioles and venules and thereby dilate both 
arteriole and venules. Peripheral vascular resistance is decreased leading to fall in BP 
with only mild tachycardia.β-blockers are mild anti-hypertensives. Blockade of 
β1receptors results in decreased myocardial contractility and cardiac output. Thus they 
reduce BP due to a fall in the cardiac output 
[29]
. 
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Table no: 3 Classification of Anti-Hypertensive Drugs 
S.NO TYPES OF DRUG NAME OF THE DRUG 
1. ACE inhibitors Captopril 
Enalapril 
Lisinopril 
Ramirpril 
2. Angiotensin antagonist Losartan  
3. Calcium channel blockers Nifidepine 
Felodipine 
Amlodipine 
Verapamil 
Diltiazem 
4. Diuretics      Hydrochlorothiazide 
Frusemide 
Indapamide 
Spironolactone 
Triamterene 
Amiloride 
5. β-adrenergic blockers Propranolol 
Atenolol 
Metaprolol 
6. α-adrenergic blockers Prazocin 
Terazocin 
Phentolamine 
7. Central sympatholytics Clonidine 
Methyldopa 
      8. Vasodilators 
(i)Arteriolar 
 
 
(ii)Arteriolar and venular 
  Hydralazine 
Minoxidil 
Diazoxide 
Sodium  
  nitroprusside 
Pinacidil 
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Ca+ channel blockers 
CCBs are another important group of anti-hypertensive. They are particularly 
used in elderly patients.CCBs may be used as mono therapy or in moderate to severe 
Hypertension along with other hypertensives (Nifedipine, Nicardipine, Nimodipine, 
Amlodipine, Felodipine, Verpamil). 
Vasodilators 
 Arteriolar dilators (Hydralazine,Minoxidil,Diazoxide) 
 Arteriolar and venular dilators(sodium nitroprusside) 
  Vasodilators relax the vascular smooth muscle thus reducing BP due to decresed 
peripheral vascular resistance. Nitroprusside is the drug of choice in hypertensive 
emergencies. It is used in situations where short-term reduction of myocardial work 
load is required as serve heart failure and myocardial infarction. 
Adverse effects of anti-hypertensive drugs 
 Angiotensin receptor blockers cause Hypotensin and Hyperkalaemia. 
 Sympatholytics like Methyldopa cause dryness of mouth and nose, depression, 
vertigo, extra-pyramidal signs, raised prolactin levels, postural hypertension. 
 Vasodilators like Hydralazine cause headache, dizziness, flushing, palpitation, 
nausea, anorexia, hypotension and saltandwater retension. 
 Sodium nitroprusside cause palpitation, sweating, weakness, nausea, vomiting 
and  hypotension
[30]
.
 
     3.3 PHARMACOLOGY REVIEW
 
 
PHARMACOLOGICAL STUDY OF ANTIHYPERTENSIVE ACTIVITY IN 
ANIMAL MODELS 
Hypertension Models 
In-Vitro Model 
 Endothelin receptor antagonism inporcine isolated hearts 
 Monocrotaline induced pulmonary hypertension 
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Endothelin Receptor model 
Endothelins(ET) have been implicated in the pathophysiology of cardiovascular 
diseases.In this model isolated porcine coronary artery is used since the smooth 
musculature of artery is considered to contain the ETA receptors.ET results in potent 
long lasting contractions of isolated blood vessel strips. An increase of blood pressure in 
vitro studies has been elicited by Endothelin peptides. 
Monocrotaline-induced pulmonary hypertension 
 Monocrotaline is a hepatotoxic pneumotoxic agent used in Rats 
pulmonary hypertension. It is a pyrolizidine alkaloid derived from crotalaria spectabilis 
and single injection leads to progressive pulmonary hypertensionfollowed by right 
ventricular hypertrophy and cardiac failure. Ultrastructural changes such as 
degeneration and fragmentation of endothelial cells and mascularization of pulmonary 
arteries, arterioles are also observed. Monocrotaline administration of rats can results in 
severe right ventricular hypertrophy accompanied by rats and pleural effusion. 
IN-VIVO MODELS 
 RAT MODELS 
I. Reno-vascular induced 
 Two-kidney one clip method(Goldblatt  hypertension,2K1C) 
 Chronic renal hypertension in rats(1-kidney-1-clip method) 
 Chronic renal hypertension in rats(Two kidney two clip method) 
II. Neurogenic induced 
 Blood pressure in pithed  rats 
  III. Diet induced 
 Fructose induced 
 Increased salt induced 
IV. Endocrine induced 
 DOCA-salt rats 
V. Psychogenic  
 Air-jet stimulation induced hypertension 
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VI. Genetically induced 
 Salt-sensitive Dahl rats 
 Spontaneously hypertensive rats 
DOG MODEL OF HYPERTENSION 
 Chronic renal hypertension 
 Neurogenic hypertension 
MONKEY MODEL OF HYPERTENSION 
 Renin inhibition in monkeys 
TRANSGENIC MODEL OF HYPERTENSION  
 Transgenic rats overexpressing the mouse Ren-2 gene[TGR(mRen 2)27] 
Two kidney one clip (Goldblatt hypertension2k1c) 
Sprague dawley rats used for this model 
Ischemia of the kidney causes elevation of blood pressure by activation of 
rennin angiotensin system. In rats clamping the renal artery for 4hrs can activates 
peripheral RAAS and sympathetic nervous system and induce renal hypertension. After 
reopening the vessel, accumulated rennin is released into circulation leading to acute 
hypertension. Renin is secreted by the kidneys when sympathetic activity is increased. 
Renin converts Angiotensin to Angiotensin I, AngiotensinII is a potent vasoconstrictor 
and increase blood pressure. Angiotensin II also causes release of aldosterone leading to 
salt and water retention result in increased blood volume and hypertension. This model 
is used to evaluate anti-hypertensive activities drugs. 
Chronic renal hypertension (one kidney one clip method) 
The one kidney one clip method is the technique has been described several 
animal species.ne the most effective modifications in rats in which one kidney is 
removed. Constriction of one kidney is done on one side and the contralateral kidney is 
removed. There is an increase in blood pressure within few hours. Since there is no 
other kidney, there is no pressure, dieresis and natriuresis, so there is rapid salt and 
water retention. Plasma rennin activity is usually normal. Hypertension soon becames 
volume  dependent. 
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Blood pressure in pithed rats 
Male wistar rats (250-350 gms) are used in this model 
The pithed rat model is divided for neurogenic reflex control that may modulate 
the primary drug effect. It is frequently used to evaluate drug action on the 
cardiovascular system. 
Salt-sensitive Dahl rats 
The kidneys have the ability to excrete easily the daily salt load without 
allowing a marked rise in extracellular volume. Chronic ingestion of excess salt 
produces hypertension in rats, which mimics human hypertension. The salt-sensitive 
dahl develop severe and fatal hypertension when fed high salt diets. This is the model of 
genetic hypertension, with the extra feature of Salt sensitivity. 
Fructose induced hypertension in rats 
Feeding a high fructose diet induces hypertension and insulin resistance in 
Sprague dawley rats.Fructose feeding also causes insulin resistance,hyperinsulinemia 
and hypertriglyceridemia in normal rats.Fructose feeding induces hypertension in 
normal or high salt feed animals and it is associated with an increased expression of the 
Angiotensin II type I receptor in adipose tissue.AT 1 receptor play a role in the 
pathophysiology of metabolic and hemodynamic abnormalities induced b fructose 
feeding. 
DOCA-salt rats 
Mineralocorticoids induces hypertension by causing in plasma and exracellular 
volume. The administration of deoxycorticosterone acetate(DOCA) ,a mineralocorticoid 
in combination with high salt diet and unilateral nephrectomy induces hypertension. 
There is increased DOCA induced reabsorption of salt and water leading to increased 
blood volume and hence increased blood pressure
[31]. 
Spontaneously hypertensive rats 
By breeding strain of spontaneous hypertensive wistar rats with a female having 
slightly raised blood pressure, Okamoto and Aoki obtained a strain of rats spontaneous 
hypertension,the SHR. Spontaneous Hypertension was devopled by meticulous genetic 
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in breeding that uniformly resulted in 100% of progeny having naturally occurring 
hypertension. Several researchers reported the spontaneous hypertension is an excellent 
model of experimental hypertension as well as model for complications of 
hypertension
[32]
. 
Transgenic rats overexpressing the mouse Ren2 gene[TGR(mRen2)27] 
The ability to specifically introduce genetic constructs and thereby breed 
transgenic animal has opened new possibilities for hypertension research. Recently a 
transgenic rat has been obtained after introduction of the entire mouse Ren 2d gene. The 
introduction and over expression of mouse Ren2d in this rat leads to severe, lethal in the 
homozygous rat. 
Method for the measurement of blood pressure in rats 
 Tail-cuff method in rats 
 Indwelling catheter for measurement of blood pressure in conscious rats. 
Tail cuff method for measuring Bp 
The indirect tail cuff method allows the measurement of BP without any surgical 
procedure. The principle used in this method is that the pulse obliterate when the cuff is 
inflated  till above suspected systolic blood pressure. The pulse reappears as the 
pressure in the cuff is slowly released and it falls below the systolic blood pressure. The 
method is analogous to sphygmonometry in humans. 
The indirect tail cuff method is widelyused to evaluate the influence 
ofantihypertensive drugs in spontaneouslyand experimentally induced hypertensive rats. 
Indwelling catheter method 
This method allows directly measurement of blood pressure in conscious rat. 
The influence of anesthesia on the cardiovascular regulation is eliminated by this 
method. 
7 cm long cannulae are prepared by cutting pe 10 and pe 20tubing respectively. 
A style wire is inserted into the pe10 tubing is also slipped over the style wire. The tube 
ends are heated in a current of hot air and fused together. Using ridges the style wire is 
left inside the cannula and the cannula is heated in a jet of hot air. When the 
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polyethelene at the point of heating becomes soft,the cannula is pressed slightly and the 
ridges are formed. 
Dog models of hypertension 
 Chronic renal hypertension 
 Neurogenic hypertension 
Chronic renal hypertension 
Partial constriction of renal arteries in dogs produces hypertension. This method 
is modified and is now known as the wrapping technique.A sheet of cellophane is 
placed around the kidney and held in place by silk sutures tied loosely around the renal 
hilus. Both kidneys are wrapped or one kidney is wrapped and other is removed. A fibro 
collagenous shell is formed around the kidney in 3-5 days because of reaction of the 
tissue to the foreign material. This shell compresses renal vascular pressure. This 
expands the extracellular volumeleading to increased peripheral resistance and hence 
increased blood pressure. 
Neurogenic hypertension  
Baroreceptors situated in the carotid sinus and aortic arch play an important part 
in the regulation blood pressure stimulation of baroreceptor causes inhibition of 
vasomotor center leading to vasodilatation, bradycardia and decrease in blood pressure. 
Sectioning of the baroreceptor nerves leads to persistant raise in blood pressure. Thus 
this produce acute neurogenic hypertension  induced in dogs.  
Renin inhibition method in monkey 
 Blood pressure is mainly regulated by the rennin Angiotensin system and 
can be influenced by the inhibition of rennin. Renin inhibitors developed for have a high 
specifically for primate rennin and cause only weak inhibition of rennin sub primate 
species. It suggests that most commonly laboratory animals such as dog are not suitable 
for in-vivo evaluvation of rennin inhibitor. Marmosets (callithrix jacchus) of 300-
400gare fedpellet diet supplemented with fruits. These animals were used for rennin 
inhibition method 
[33]
. 
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ANIMAL MODEL FOR THE DISSERTATION 
SPONTANEOUSLY HYPERTENSIVE RATS: 
Systolic blood pressure (SBP) and heart rate measurement of SH rats was 
carried out using tail-cuff method plethysmography (LE 5001 Pressure Meter). A mean 
of six measurements was obtained for each animal. For blood pressure measurement, 
the animals were warmed up to 42°C for 5 min in a confinement cage. The animals 
were first submitted to a period of adaptation for 15 days before the experiments and 
only SHR with an SBP > 170 mmHg were selected for this study. During the final 
week of the treatment, the rats were allowed to acclimatize to the experimental 
conditions of noninvasive SBP measurements by allowing them to stand in rat 
restrainers for 30 min every day. SBP measurements were recorded 24 h after the last 
treatment dose. At least 8-10 recordings were taken for each rat and the mean of the 
lowest 4 values within less than 10 mmHg difference was taken as the mean SBP. 
   3.4 PHARMACEUTICAL REVIEW 
CHOORANAM  
Definition 
Chooranam is a fine powder  of drugs. The “Chooranam” may be applied to the 
powders of a single drug or a mixture of two or more drugs, which are powdered 
separately prior to their being mixed to homogeneity[34]. 
Method of preparation 
Equipment required 
1. The drug enumerated in the recipe in clean and well dried state. 
2. A mortar and pestle. 
3. A fine sieve or fine cloth of close mesh. 
Process of preparation 
The drugs which are to be used in the preparations should be taken from recently 
collected material. Drugs which are aged by prolonged storages or changed in colour, 
taste and scent and those that are insects infested or attacked by fungi should be 
positively rejected. 
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However drugs like Embelia fruits, Senna, Long Pepper, Jaggery and cows ghee 
are preferred from fairly aged stock, provided they are not infested with pests, 
deteriorated or spoiled or developed racidity. 
In general the aromatic drugs are slightly fried in order to enhance their aroma 
and milling properties. Any extraneous material, organic or inorganic, should be 
removed from the drugs by close inspection. 
  The chooranam should be so fine to be called amorphous and should never be 
damp. The fineness of the sieve should be no 100 mesh or still finer. 
Purification of the prepared chooranam 
“தாபென்ற சூரணத்தின் சுத்திக்ககளு 
தப்ொகத சரக்பகல்லாஞ் சூரணித்து 
நாபென்ற வாவின் ொலாற் ெிரசந்து 
நல ாெ சட்டியிகல ொரலவிட்டு 
வாபென்ற சுத்தசலம் ொதிவிட்டு  
வள ாக க ற்சீரல ககாடு கட்டிப் 
ொபென்ற சூரணத்ரதப் ெிட்டுகொல் ரவது 
ெதறாகத பவந்பதடுக்க்ச் சித்தியக ” 
                                   -   அகஸ்தியர்ரவத்தியஇரத்திெச்சுருக்கம்[35] 
  The prepared chooranam is mixed with the milk in a  pot half quantity milk and 
half a quantity water is taken. The mouth of the pot is covered with a thin cloth material. 
Above this cloth the mixed chooranam is placed. The pot is placed over the stove and 
heated. 
 
            “ஆ ப்ொ ரவியுலர்த்திப் பொடிதான் பசய்து 
                   அப்ெகெ ச ொய்ச் சர்க்கரரரயச்கசர்த்து 
              நா ப்ொ பகாண்டு வர கதாஷம் கொச்சு 
                   நன்றாக்ச் சுத்தி பசய்யாச் சூரணந்தான் 
              தா ப்ொகராகத்ரதபவல்லாதப்ொ 
                   தள ாெ வியதி பயல்லாம் ொரிக்கும் ொர் 
              கவ ப்ொ சுத்தி பசய்து பகாண்டாயொல் 
                   பவகுசுறுக்காய் தீரு ா வியாதி ககளு” 
-அகஸ்தியர்ரவத்தியஇரத்திெச்சுருக்கம் 
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Then the chooranam is placed in the sunlight and powdered. Equal amount of sugar is 
added and taken internally. All type of diseases get cured. If the drug is taken without 
purification the disease does not cure. If taken after purification the disease cures easily. 
Storage 
The prepared chooranam should be allowed to cool by spreading and mixing, 
prior to packing. They should be stored in tightly stoppered glass, polythene or tin 
containers, or in polythene or cellophane bags and sealed. These bags should in turn be 
enclosed in cardboard boxes. 
The chooranam to facilitate easy handling and to assure exact dosage 
administration, could be pressed into tablets, could be packed in bottles or tubes made 
either of glass or plastic or packed in strip of metal foil or plastic sheets. 
In industry the tablets are made, counted and packed by electronic devices. 
Then chooranam is said to retain its potency for 3 months and then gradually 
deteriorate. However if properly packed and stored they keep good for a year. 
(Formulary of Siddha Medicines, 1993) 
According to AYUSH guidelines shelf life of chooranam is one year. [36] 
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Table no: 4 ANALYTICAL SPECIFICATIONS OF CURNA/CHOORNAM 
Sl.No TESTS 
1. 
 
2. 
3. 
4. 
5. 
6. 
7. 
 
8. 
 
9. 
 
 
 
 
10. 
 
 
11. 
 
 
 
 
12. 
 
 
 
 
Description 
Macroscopic, Microscopic 
Loss on drying at 105˚ C 
Total – ash 
Acid – insoluble ash 
Water-soluble extractive 
Alcohol – soluble extractive 
Particle size (80-100 mesh for Churna; 40-60 
mesh  for churna) 
Identifications,TLC/HPTLC-
withmarker(whereverpossible) 
Test for heavy/Toxic metals 
Lead 
Cadmium 
Mercury 
Arsenic 
Microbial contamination 
Total bacterial count 
Total fungal count 
Test for specific Pathogen 
E. coli 
Salmonella spp. 
S.aureus 
Pseudomonas aeruginosa 
Pesticide residue 
Organochlorine pesticides 
Organophosphorus pesticides 
Pyrethroids 
Test for Aflatoxins (B1,B2,G1,G2) 
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     3.5 Lateral Research 
Vitis vinifera:  
Grape Seed Procyanidins in Pre- and Mild Hypertension: A Registry Study 
Diuretic activity:  
The methonolic extract of grape seeds treated rats show high diuretic at a dose of 500 
mg/kg by increasing total amount of urine levels of Na+,K+ and Cl-  in urine as 
compared to control but effect was less than furosemide[37]. 
Antioxidant activity of Vitis vinifera: 
The acetone, ethyl acetate, methanol and mixtures of different solvents, such as ethyl 
acetate(EtOAc)andwater extract of vitis vinifera showed antioxidant activity through a 
β-carotene-linoleate model system and linoleic acid peroxidation method. 
In conclusion our studies identified some varieties of grapes with high antioxidant 
activities and showed that their high antioxidant potential may be due to their phenolic 
and flavonoid contents[38]. 
Zingiber officinale 
Antioxidant activity 
The ginger extract possessed antioxidant activity while evaluating using  DPPH  
assay[39]. 
Antihypertensive activity[40]: 
Zingiber officinale showed antihypertensive activity while experimentally induced 
hypertension in rats. 
Phyllanthus emblica 
Antioxidant activity[41]: 
Emblica officinalis (EO) reduces oxidative stress, prevents development and 
progression of hypertension as well as cardiac and renal hypertrophy in DOCA/HS-
induced hypertension via modulation of activated eNOS, endogenous antioxidants, 
serum NO and electrolyte levels. 
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Antihypertensive activity[42]: 
This plant Exerts Antihypertensive Effect in a Rat Model of DOCA-Salt-Induced 
Hypertension 
Piper longum: 
Antihypertensive activity[43]: 
Piperine lowering the blood pressure so it exerts antihypertensive activity. 
Antioxidant activity
[44]
: 
Choloroform extract of Piper longum (PC) showed the highest in vitro antioxidant 
activity. 
Aegle marmelos: 
Antioxidant activity[45]: 
Results of the present study reveal that the AM is a potential source of antioxidants 
which are responsible for the antioxidant activity. The stability to heat and pH of the 
different extracts of AM leaves extracts with strong antioxidant activity indicates its 
scope for utilization in food and biological systems. 
Diuretic activity[46]: 
Diuretic activity of the plant Aegle marmelos was confirmed experimentally in rats. 
Nymphaea alba: 
The ethanolic and aqueos have exhibited significant antioxidant activity in DPPH, 
Nitric oxide and Hydroxyl radical induced invitro assay methods. The results indicate 
that both the extracts firmly possess strong antioxidant effects. Comparatively the 
ethanolic flower extract showed more antioxidant activity than the aqueous extracts. 
The results obtained from the present study indicate that the Nymphaea alba flower 
extract can be a potential source of natural antioxidant[47]. 
Antioxidant activity of cyperus rotundus[48]: 
The hydroalcoholic extract of C. Rotundus expressed its antioxidant potential while 
evaluated pharmacologically using In vitro model free radical scavenging assay. 
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Phoenix dactilifera 
Antioxidant activity[49]: 
Variety of dates such as Khalas and Ajwa exhibited their antioxidant potentials 
in aqueous and alcoholic extract  through DPPH assay. 
Cinnomomum tamala 
Antioxidant activity[50]: 
One research study concluded that synaptosomes from diabetic rats are 
susceptible to oxidative damage and the positive effects of bay leaf in vitro, 
could be attributed to the presence of antioxidant phytochemicals. 
Diuretic activity[51]: 
The aqueous and ethanolic extracts of Cinnamomum tamala leaves were 
investigated for its diuretic activity tested in albino rats. Results revealed that 
both the alcoholic and aqueous extracts showed significant diuretic activity at a 
dose of 500mg/kg body weight by increasing the total volume of urine and 
concentrations of Potassium and Sodium salts in urine as compared to the 
standard drug Frusemide. 
Terminalia bellerica 
Antioxidant activity[52]: 
The free radical scavenging activity and antioxidant potential of acetone 
extract/fractions of its fruit was investigated using in vitro assays, including 
scavenging ability against 2,2'-diphenyl-2-picrylhydrazyl (DPPH), beta-carotene 
bleaching inhibition, reducing power and chelating ability on Fe2+ ions. It was 
found that ethyl acetate fraction was more effective than crude acetone extract in 
all antioxidant assays, except chelating power which was highest in water 
fraction. Maximum antioxidant activities (expressed as EC50 values) observed 
were 14.56 microg/ml, 27.81 microg/ml and 67.8 microg/ml in DPPH, beta-
carotene bleaching and reducing power assays, respectively. The antioxidant 
potential was compared with known antioxidant (butylated hydroxyl toluene) 
and correlated with total phenolic and flavonoid content in crude extract and 
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fractions. Fractions rich in polyphenolic content were more effective than the 
crude extract. 
Diuretic activity[53]: 
 The study aim to evaluate potency and efficacy of Terminalia belerica fruit pulp 
aqueous extract (TBFPAE) in Wistar albino rats as a diuretic. TBFPAE possesses 
diuretic effect with a significant Potassium-sparing effect comparable to frusemide in 
the dose of 9, 18, and 36 mg/kg in Wistar albino rats comparable to frusemide. 
Sandal 
Safety assessment of sandal wood oil (Santalum album L.S) 
Over 100 constituents of sandal wood oil have been identified with major 
constituents being alpha-santalol. Sandal wood oil was mutagenic in spore Rec assay 
and was found to have Anti-carcinogenic, Anti-viral and anti-bacterial activity 
[54]
. 
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4. MATERIALS AND  METHODS 
4.1 Drug selection:  
In this research work, the “Munthirikai Choornam”, a poly herbal formulation, 
has been selected to evaluate Hypertension, mentioned in “Aathma Ratchamirtha 
Vaithiya Saara Sangiragam” p.no:206. 
Ingredients: 
 Munthirikai pazham (Vitis vinifera)             
 Thipilli moolam (Root of piper longum) 
 Thiri kadugu  
Chukku  (zingiber officinale) 
Milagu (Piper nigrum) 
Thippili (Piper longum) 
 Sengkazhunir (Nymphaea alba) 
 Vetiver (Vetiveria zizanioides) 
 Chandanam (Santalum album) 
 Vilamichu (Plectranthus vettiveroides) 
 Atimaduram  (Glycyrrhiza glabra) 
 Muthakkasu  (Cyperus rotandus) 
 Vilva poo  (Aegle marmelos) 
 Yelarisi  (Eletaria cardamom) 
 Kothumalli  (Coriandrum  sativum) 
 Thiripala  
 Kadukai (Terminalia chebula) 
Nellikkai (Phyllanthus emblica) 
Thandrikkai (Terminalia bellarica) 
 Ner pori (Oryza sativa) 
 Pericham pazham (Phonex dactilifera) 
 Patchai karpooram (Borneo camphor) 
 Karkandu (Rock candy) 
 Lavanga pathiri (Cinnamomum tamla) 
 Chiru nagappu (Mesua nagassarium) 
 Koogai neeru  (Marantu arundinacea) 
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Source of Collection 
        The drug was purchased from authorized country Raw Drug Store in Chennai. 
Identification and Authentication of the drug 
 The collected raw materials and plants were identified and authenticated by 
Botanist and faculties of Gunapadam department, Government Siddha Medical College, 
Arumbakkam, Chennai, and Tamilnadu. A specimen sample of each raw material has 
been kept in the department for future reference. 
(Reg. No: GSMC/PGGM/072-095/2014-17) 
Purification of the ingredients 
All the drugs mentioned here were purified as per the Siddha literature. 
[55] 
 The outer skin of Sandal woods, Turmeric, Tree turmeric were peeled off. 
 The adventious roots of Nut grass were removed and dried. 
 The roots of Cuscus grass cut into small pieces and dried in sunlight. 
 Chukku was immersed by using limewater then it was dried in sunlight, finally 
the outer layer of skin were peeled off. 
 Dried fruit of Indian gooseberry was boiled with milk and the seeds were 
removed. 
 The root of Indian liquorice was cleaned with water and cut into small                          
pieces and then dried. 
 Nerpori-cleaned the dust particles 
 Kadukkai-roasted in pan, inner seed was removed. 
 Korai-kizhangu were washed in the running tap water to remove the soil and 
impurities. 
 Thippili-Immersed in lemon juice and dried. 
 Thippilli moolam-Nodes were removed and dried. 
 Milagu-It was immersed in sour buttermilk for75minutes and dried. 
 Dried fruits of Nelli (Phyllanthus emblica) were first dusted with a clean cloth 
and then purified by gently removing the outer skin.  
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Preparation of Munthirikai Chooranam 
 
 
Procedure:   The ingredients after purification were ground separately to powder. The 
powder was sieved through a white cloth (Gunapadam Thathu JeevaVagupu) .All 
these powdered ingredients were mixed thoroughly in a stone mortar. The prepared test 
drug was stored in a clean, air tight glass container. The contents were inspected 
frequently to avoid moisture and insects. It was labelled as “Munthirikai Chooranam’’ 
(MC). 
Purification of the Chooranam: steaming process (Pittaviyalmurai) 
The MC was purified by pittaviyal method (steam cooking in milk) as per 
Siddha classical literature. A mud pot was taken and it was half filled by mixture of 
milk with equal quantity of water. The mouth of the pot was sealed by a cloth. This 
Chooranam was placed over the cloth and tied firmly around the mouth of mud pot by 
another pot. The gap between mud pots was tied with a wet cloth to avoid evopration. 
The mud pot was kept on fire and boiled until the cow’s milk reduced in the lower pot. 
The same drug was later dried and powdered then sieved again. It was used for the 
further study [56] . 
Storage of the drug  
The prepared test drug was stored in a clean, air tight glass container. The 
contents were inspected frequently to avoid moisture and insects. 
Administration of the drug 
Form of medicine  : Chooranam 
Root of administration : Enteral  
Dosage              : 2 Gram twice a day- after food  
Vehicle     : Milk 
4.2 STANDARDISATION OF THE DRUG 
Standardisation of the drug brings the validation to be used as a medicine by subjecting 
the drug to many analysis and determining its quality and effectiveness. Standardization 
includes many studies such as its organoleptic properties, physical characteristics  and  
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phytochemical  properties and also to assess the active principles and elements present 
in the drug. Thus standardization brings the efficacy and potency of the drug. 
4.2.1 Organoleptic character 
The organoleptic characters of the sample drug were evaluated.1gm of the test 
drug was taken and the colour, texture, particle size and other morphology were viewed 
by naked eye under sunlight. Then the result is tabulated in Table no:9 
4.2.2 Physicochemical Analysis 
Physicochemical studies of the trial drug have been done according to the WHO 
guidelines [57]. 
Determination of Ash Values 
Total Ash 
3g of the test drug was accurately weighed and incinerated in a crucible dish at a 
temperature not exceeding 450
o
C until it was free from carbon. It was then cooled and 
weighed. The % W/w of ash with reference to the air-dried powder was calculated. 
Water Soluble Ash 
The total ash was obtained as the above method for preparation of total ash. The 
ash was boiled with 25ml of water for 5minutes. The insoluble ashes were collected 
using filter paper. It was then washed with hot water and transferred to the silica 
crucible. It was then ignited for 15minutes at temperature not exceeding 450
o
C. For 
determination of weight of the water soluble ash the silica crucible and residue were 
weighed until constant weight was attained. The weight of the water soluble ash was 
determined by subtracting the weight of insoluble ash from the weight of total ash. 
Acid insoluble Ash 
The total ash was obtained as the above method for preparation of total ash. The 
ash was boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes were collected 
using filter paper and washed with hot water. It was then transferred to the silica 
crucible and ignited for 15minutes at temperature not exceeding 450
o
C. The silica 
crucible and residue were weighed until constant weight is attained. 
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Determination of Extractive Value 
Alcohol Soluble Extractive Value  
3g of test drug powder was weighed and macerated with 100ml of ethanol in a 
closed container for 24 hours. The resulting solution was shaken continuously for 6 
hours.It was then allowed to stand and soak for 18 hours. The solution was filtered and 
evaporated of the filtrate in a flat bottomed shallow dish and dried at 105
o
C. Then the 
content was cooled and weighed. 
Water soluble Extractive value 
3g of test drug powder was weighed and macerated with chloroform and water, 
respectively, at 80
o
C for 24 hours. The resulting solution was shaken continuously for 6 
hours and allowed to stand and soak for 24hours then filtered. The solution from both 
chloroform and water respectively was filtered and evaporated of the filtrate in a flat 
bottomed shallow dish. It was dried at 105
o
C then cooled and weighed. 
Loss on Drying 
The powdered drug was taken and dried in the oven at 100- 105°C to constant 
weight. The result was noted.  
Physical characterization 
Solubility 
 A little of the sample was shaken well with distilled water and then little of the 
sample was shaken well with con Hcl and Con H2SO4. Sparingly soluble character 
indicates the presence of Silicate. 
pH value 
Potentiometrically pH value was determined by a glass electrode and a suitable 
pH meter. 
Action on heat 
 A small amount of the sample was taken in a dry test tube and heated gently. If 
there was a strong white fumes evolving it indicates the presence of Carbonate. 
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Flame test 
A small amount of the sample was made into a paste with con.Hcl in a watch 
glass. It was then introduced into non-luminous part of the Bunsen flame. Appearance 
of bluish green flame indicates the presence of Copper. 
Ash Test 
A filter paper was soaked into a mixture of sample and cobalt nitrate solution. It 
was then introduced into the Bunsen flame and ignited. Appearance of yellow colour 
flame indicates the presence of Sodium.      
All the results were noted and tabulated in Table no:10 
4.2.3 Phytochemical Analysis  
The Phytochemical screening of the extract gives general idea regarding the 
nature of chemical constituents present in the crude drug. The phytochemical tests were 
done as the method illustrated in [58]. 
Test for Alkaloids 
A small portion of solvent free extracts was stirred separately with few drops of 
dilute hydrochloric acid and filtered & tested carefully with various  alkaloidal reagents. 
Mayer’s reagent  - Cream precipitate 
Dragendroff’s reagent - Orange brown precipitate 
Hager’s reagent  - Yellow precipitate 
Wagner’s reagent  - Reddish brown precipitate 
Test for Carbohydrates and Reducing Sugars 
The minimum amount of extracts was dissolved in 5ml of distilled water & 
filtered. The filtrate was subjected to test for carbohydrates & glycosides. 
a) Molisch’s test 
The filtrate 1 ml was treated with 2-3 drops of 1% alcoholic alpha naphthol& 
2ml concentrated sulphuric acid was added along the sides of test tube. Violet ring was 
observed at the junction of 2 layers which showed the presence of carbohydrate. 
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b) Benedict’s test  
The filtrate 1 ml was treated with Benedict’s reagent and heated gently. Orange 
red precipitate indicates the presence of reducing sugars. 
c) Fehling’s test  
The filtrate 1 ml was treated with equal volume of Fehling’s solution A and B 
and heated gently. Orange red precipitate indicates the presence of reducing sugars. 
Test for Glycosides 
The extract was hydrolyzed with dil. HCl and subjected to test for glycosides. 
a) Modified Borntrager’s test 
To the hydrolysate extract, 1 ml of Ferric chloride solution was added and 
immersed in boiling water for about 5 min. The mixture was cooled and extracted with 
equal volume of benzene. The benzene layer was separated and treated with ammonia 
solution. Formation of rose pink colour in the ammoniacal layer indicates the presence 
of Anthranol glycosides. 
b) Legal’s test 
The hydrolysate extract was treated with Sodium nitropruside in pyridine and 
sodium hydroxide. Formation of pink to blood red colour indicates the presence of 
Cardiac glycosides.  
Test for Saponins  
The extract 0.5 ml was shaken with 5 ml distilled water. The presence of 
saponins was indicated by formation of copious lather. 
Test for Tannins 
Gelatin test  
To the extract, 1% gelatin solution containing sodium chloride was added. 
Formation of white precipitate indicates the presence of tannins. 
Test for Phenolic compounds 
To 0.5 ml of extract, 1 ml of alcoholic ferric chloride solution was added. 
Formation of bluish green or bluish black indicates the presence of Phenolic 
compounds. 
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Test for Phytosterol 
Ferric chloride – acetic acid test 
1 ml of extract was treated with 1 ml of chloroform and then, 2 ml of ferric 
chloride acetic acid reagent was added followed by 1 ml of conc. sulphuric acid. 
Appearance of reddish pink colour shows the presence of phytosterol. 
Test for Diterpenes 
Copper acetate test 
1 ml of extract was dissolved in water and treated with 3-4 drops of Copper 
acetate solution. Formation of emerald green colour indicates the presence of 
diterpenes. 
Test for Triterpenes 
Salkowski’s test  
1 ml of extract was treated with 1 ml of chloroform followed by 1 ml of conc. 
sulphuric acid, shaken and allowed to stand. Appearance of golden yellow colour shows 
the presence of triterpenes. 
Test for Flavonoids 
a) Alkaline reagent test 
To 1 ml of extract, 1 ml of 10% sodium hydroxide solution was added. 
Formation of dark yellow colour indicates the presence of flavonoids. 
b) Lead acetate test 
To 1 ml of extract, 3-4 drops of 10% lead acetate solution was added. Formation 
of yellow precipitate indicates the presence of flavonoids. 
c) Ferric chloride test 
To 1 ml of extract, 3-4 drops of ferric chloride solution was added. Formation of 
dark green colour indicates the presence of flavonoids. 
d) Shinoda test 
To 1 ml of extract, few mg of magnesium turnings was added followed by few 
drops of conc. hydrochloric acid and boiled for five minutes in a boiling water bath. 
Formation of red colour indicates the presence of flavonoids. 
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Test for Proteins and Free Amino Acids 
a) Xanthoproteic test 
To 1 ml of extract, 3-4 drops of conc. nitric acid was added. Formation of 
yellow precipitate indicates the presence of proteins. 
b) Million’s test 
To 0.5 ml of extract, 2.5 ml of Million’s reagent was added. Formation of white 
precipitate and the precipitate warmed indicates the presence of proteins. 
c) Biuret test  
To 0.5 ml of extract, 2.5 ml of diluted Biuret reagent was added.  Appearance of 
purple colour or brick red precipitate showed the presence of proteins and free amino 
acids. 
Test for Quinones 
Sodium hydroxide test 
To 0.5 ml of extract, 1 ml of 10% sodium hydroxide was added.  Appearance of 
blue or green or red colour shows the presence of quinones. 
 Results of phytochemical analysis were noted and tabulated in Table no: 11 
TLC/ HPTLC finger print studies  
HPTLC finger printing was carried out as per the reference [59]. 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add  5ml of cooled 
concentrated sulphuric acid then Ice was added and stirred well. The solution was 
stored in refrigerator.   
Chromatographic conditions  
Instrument        :  CAMAG (Switzerland). 
Sample Applicator      :  Camag Linomat - IV applicator with N2 gas flow 
Photo documentation System : Digi store - 2 documentation system with Win Cat 
&video scan software. 
Scanner      :  Camag HPTLC scanner - 3 (030618), Win Cats - IV.  
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Development Chamber     :  Camag HPTLC 10X10, 10 X 20 twin trough linear 
      Development chamber. 
Quantity applied     :  5, 10 µl for extracts and 5 µl for standards 
Stationary phase                       : Aluminium plate pre-coated with silica gel60(E.Merck) 
Plate thickness      :   0.2 mm. 
Mobile Phase    :    For Chloroform extract - Toluene: Ethyl acetate (9:1) 
 and ethanol extract - Toluene: Ethyl acetate (1:1).   
Scanning wavelength    :   254 nm 
Laboratory condition    :   26 ± 5
o
C and 53 % relative humidity 
The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using 
vanillin-sulphuric acid reagent heated at 105° till colour spots appeared.  
HPTLC results were noted and tabulated in Table no: 12,13 
4.2.4 Bio-Chemical Analysis 
Preliminary Basic and Acidic radical studies  
Methodology for chemical analysis 
Preparation of extract 
5gm of  MC was weighed accurately and placed in a 250ml clean beaker and 
added with 50ml of distilled water. Then it was boiled well for about 20 minutes. Then 
it was cooled and filtered in a 1000ml volumetric flask and made up to 100ml distilled 
water. 
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         Table No.5.Test for basic radicals 
PROCEDURE OBSERVATION INFERENCE 
Test for Potassium 
A pinch of sample is treated with 2ml of 
sodium nitrate solution and then treated 
with 2ml of cobalt nitrate in 30% of 
glacial acetic acid. 
 
Formation of Yellow 
colour precipitate 
Presence of 
Potassium 
Test for Calcium 
Taken2 ml of extract in a clean test tube. 
Then acetic acid and potassium chromate 
solution were added. 
 
No Yellow precipitate 
Presence of 
Calcium 
Test For Magnesium 
2ml of extract was taken in a clean test 
tube, few drops of  Magnason reagent was 
added in drops. 
 
Formation of  Blue  
colour precipitate 
 
Presence  of 
   Magnesium 
Test For Ammonium 
2mlof extract was taken in a test tube and 
added few ml of Nessler's reagent. 
 
Appearance of Brown 
colour. 
 
Presence of 
Ammonium 
Test For Sodium 
2 pinches of MC was mixed with HCl and 
made it into paste. And introduced into 
the blue flame of Bunsen burner. 
 
 
Appearance of intense 
Yellow colour 
 
 
Presence of 
Sodium 
Test for Iron (Ferrous)   
2ml of extract was taken in a clean dried 
test tube and conc. HNO3 and ammonium 
thiocyanate were added. 
 
Appearance of Blood 
red colour 
 
Presence of 
Ferrous iron 
Test For Zinc 2 ml of the extract was 
taken in a test tube and Potassium ferro 
cyanide solution was added.  
 
Formation of White 
colour precipitate 
 
Presence  of 
        Zinc 
Test For AluminiumTo the 2m1of the 
extract was taken in a test tube sodium 
hydroxide drops were added to it. 
 
White precipitate 
obtained 
 
Presence of 
    Aluminium 
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           Results were noted and tabulated in Table No:14     
  
          Table No.6.Test for acidic radical 
PROCEDURE OBSERVATION INFERENCE 
Test For Lead: 
2 ml of extract was taken in a test tube 
and added with 2ml of potassium iodide 
solution. 
 
Formation of yellow 
colour precipitate 
 
Presence of 
       Lead 
Test for Copper: 
    To a small portion of a extract dilute 
hydrochloric acid was added and then 
hydrogen sulphide gas is passed through 
the solution. 
 
 
Black precipitate 
 
 
Presence of 
Copper 
 
Test For Mercury: 
2m1 of the extract was taken in a test tube 
and treated With 2ml of sodium 
hydroxide solution. 
 
Formation of Yellow 
precipitate 
 
 
Presence of 
Mercury 
 
Test for Arsenic:       
2m1 of the extract was taken in a test tube 
and treated with 2ml of sodium hydroxide 
solution. 
Formation of 
brownish red 
precipitate 
Presence of 
Arsenic 
PROCEDURE OBSERVATION INFERENCE 
Test for Sulphate: 2 ml of the 
extract was taken in clean, dry test 
tube and 5 % barium chloride 
solution was added to it. 
 
Formation of white 
precipitate 
 
Presence of 
Sulphate 
Test for Chloride: The extract 
was taken in a test tube and then 
treated withSilver nitrate solution. 
 
Formation of White 
precipitate 
 
Presence of 
Chloride 
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Results were noted and tabulated in Table no: 15 
4.2.5 Availability Of Microbial Load 
Enumeration of bacteria by plate count – agar plating technique[60] 
The plate count technique was one of the most routinely used procedure because 
of the enumeration of viable cells by this method.  
Principle:  
This method is based on the principle that when material containing  bacteria 
was cultured, every viable bacterium develops into a visible colony on a nutrient agar 
medium. Therefore the number of colonies, are the same as the number of organisms 
contained in the sample. 
 
PROCEDURE OBSERVATION INFERENCE 
Test for Phosphate: 
The extract was taken in a test 
tube and treated with ammonium 
molybdate and conc. HNO3. 
 
Formation of Yellow 
precipitate 
 
Presence of 
Phosphate 
Test for Carbonate :           
The substance was taken in a 
clean dry test tube and then 
treated with Conc. HCl. 
 
Formation of 
Effervescence 
Presence of 
Carbonate 
Test for Fluoride & Oxalate: 
2ml of extract was taken in a test 
tube and added with 2ml of 
dil.acetic acid, 2ml calcium 
chloride solution and then heated. 
 
Formation of cloudy 
appearance 
 
Presence of 
Fluoride & 
Oxalate 
Test For Nitrate: 
1gm of the MC was heated with 
copper turnings and concentrated 
H2SO4 and observed the test tube 
vertically down. 
 
Characteristic changes 
 
Presence of 
Nitrate 
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Dilution:  
A small measured volume are mixed with a large volume of sterile water or 
saline called the diluent or dilution blank. Dilution are usually made in multiples of ten. 
A single dilution was calculated as follows: 
 
               Volume of the sample 
Dilution  = 
            Total volume of the sample and the diluents 
 
Requirements 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter  
Procedure: 
 Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
 Prepare the initial dilution by adding 1 ml of the sample into a 9 ml dilution 
blank labelled 10
-1
 thus diluting the original sample 10 times. 
 Mix the contents by rolling the tube back and forth between hands to obtain 
uniform distribution of organisms. 
 From the first dilution transfer 1 ml of the suspension while in motion, to the 
dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the original 
specimen to 100 times. 
 From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
 Repeat this procedure till the original  sample have been diluted 10,000,000 
times using every time a fresh sterile pipette. 
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 From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes are to 
used for each dilution. 
 Add approximately 15 ml of the nutrient medium, melted and cooled to 450c, 
to each petri dish containing the diluted sample. Mix the contents of each 
dish by rotating gently to distribute the cells throughout the medium. 
 Allow the plates to solidity. 
 Incubate  these plates in an inverted position for 24-48 hours at 370c. 
Observation: 
Observe all the plates for the appearance of bacterial colonies. Count the number 
of colonies in the plates. 
Calculate the number of bacteria per ml of the original suspension as follows: 
    Number of colonies (average of 3 replates) 
Organisms per millimeter =  
    Amount of plated × dilution 
 
4.2.6 INSTRUMENTAL ANALYSIS 
  
                  Fourier Transform Infra-Red spectroscopy 
                       
                  Fig no:2.1 FTIR-INSTRUMENT 
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           Fig no: 2.2 FTIR-MECHANISM 
Model Details 
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   :  MIR 450-4000 cm-1 
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid. 
It is the preferred method of infrared spectroscopy. FT-IR is an important and 
more advanced technique. It is used to identify the functional group, to determine the 
quality and consistency of the sample material and can determine the amount of 
compounds present in the sample. It is an excellent tool for quantitative analysis 
[61].
In 
FT-IR infrared was passed from a source through a sample (MC). This infrared was 
absorbed by the sample according to the chemical properties and some are transmitted. 
The spectrum that appears denotes the molecular absorption and transmission. It forms 
the molecular fingerprint of the sample. Like the finger print there was no two unique 
molecular structures producing the same infrared spectrum. It was recorded as the 
wavelength and the peaks seen in the spectrum indicates the amount of material present.  
FT-IR is the most advanced and the major advantage is its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated   
Results were noted and tabulated in Table no: 17 
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XRD (X-RAY POWDER DIFFRACTION) 
DEFINITION 
X-ray powder diffraction is most widely used for the identification ofunknown 
crystalline materials (e.g. minerals, inorganic compounds). Determination of unknown 
solids is important to studies in geology, environmental science, material science and 
biology. 
 
                            
                           Fig no: 3 Image of XRD Analyser 
Applications: 
 Characterization of crystalline materials [62] 
 Identification of fine-grained minerals such as clays and mixed layer clays that 
are difficult to determine optically 
 Determination of unit cell dimensions. 
With specialized techniques, XRD can be used to: 
 Determine crystal structures using Rietveld refinement 
 Determine of modal amounts of minerals (quantitative analysis) 
Characterize thin films samples by 
 determining lattice mismatch between film and substrate and 
toinferring stress and strain. 
 determining dislocation density and quality of the film by 
rockingcurve measurements. 
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 Measuring super lattices in multilayered epitaxial structures. 
 Determining the thickness, roughness and density of the film using 
glancing incidence X-ray reflectivity measurements. 
 Make textural measurements, such as the orientation of grains, in 
apolycrystalline sample. 
Strengths and Limitations of X-ray Powder Diffraction 
Strengths 
 Powerful and rapid (< 20 min) technique for identification of an 
unknown mineral. 
 In most cases, it provides an unambiguous mineral determination 
 Minimal sample preparation is required 
 XRD units are widely available 
 Data interpretation is relatively straight forward. 
Limitations 
 Homogeneous and single phase material is best for identification of 
unknown 
 Must have access to a standard reference file of inorganic compounds 
 Requires tenths of a gram of material which must be ground into a 
powder.For mixed materials, detection limit is ~ 2% of sample 
 For unit cell determinations, indexing of patterns for non-isometric 
crystalsystems is complicated. 
Sample Collection and Preparation 
Determination of an unknown requires: the material, an instrument for grinding, 
and a sample holder. 
 Obtain a few tenths of a gram (or more) of the material, as pure as 
possible 
 Grind the sample to a fine powder, typically in a fluid to minimize 
inducing extra strain (surface energy) that can offset peak positions, and 
to randomize orientation.  
 Powder less than ~10 μm(or 200-mesh) in size is preferred place into a 
sample holder or onto the sample surface 
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SEM (SCANNING ELECTRON MICROSCOPE) 
In scanning electron microscope high-energy electron beam was focused 
through a probe towards the sample (MC) material. Variety of signals was produced on 
interaction with the surface of the sample. This results in the emission of electrons or 
photons and it was collected by a appropriate detector.  
 
                              
   Fig no : 4.1 SEM-INSTRUMENT 
                 
 
 
Fig no: 4.2 SEM - MECHANISM 
In scanning electron microscope high-energy electron beam was focused 
through a probe towards the sample (MC) material. Variety of signals was produced on 
interaction with the surface of the sample. This results in the emission of electrons or 
photons and it was collected by a appropriate detector.  
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The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external 
morphology, texture, its crystalline structure, chemical composition and it displays the 
shape of the sample 
[63]
. 
ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC EMISSION 
SPECTROMETRY) 
 
                    
                     Fig no:5.1 ICP-OES INSTRUMENT 
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                Fig no. 5.2 MECHANISM OF ICP-OES 
Manufacturer : Perkin Elmer 
Model    :  Optima 5300 DV ICP-OES Inductively Coupled Plasma Spectrometer (ICP) 
Principle: 
An aqueous sample (MC) was converted to aerosols via a nebulizer. The 
aerosols are transported to the inductively coupled plasma which is a high temperature 
zone (8,000– 10,000ºC). The analysts are heated (excited) to different (atomic and/or 
ionic) states and produce characteristic optical emissions (lights). These releases are 
separated based on their respective wavelengths and their strengths are measured 
(spectrometry). The intensities are proportional to the concentrations of analyses in the 
aqueous sample. The quantification is an external multipoint linear standardization by 
comparing the emission intensity of an unknown sample with that of a standard sample. 
Multi-element calibration standard solutions are prepared from single- and multi 
element primary standard solutions. With respect to other kinds of analysis where 
chemical speciation is relevant (such as the concentration of ferrous iron or ferric iron), 
only total essential concentration is analysed by ICP-OES. 
Application: The analysis of major and minor elements in solution samples. 
Objectives: 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument 
 Develop and put on a method for the ICP-OES sample analysis 
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 Enhance the instrumental conditions for the analysis of different elements 
 Probes the outer electronic structure of atoms 
Mechanism:  
In plasma emission spectroscopy (OES), a sample(MC) solution was presented 
into the core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited and 
emit light at their characteristic wavelengths. This light is collected by the spectrometer 
and passes through a diffraction grating that serves to resolve the light into a spectrum 
of its essential wavelengths. Within the spectrometer, this deflected light was then 
collected by wavelength and amplified to yield an strength of  measurement that can be 
converted to an elemental concentration by comparison with standardizationvalues.The 
Inductively coupled plasma optical emission spectrometric (ICP-OES) analysis was 
done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer Optima 5300 DV 
[64]
.  
Results were noted and tabulated in Table no:18 
4.3 TOXICOLOGICAL STUDIES 
4.3.1 ACUTE ORAL TOXICITY STUDY OF MC 
(OECD GUIDELINE – 423) 
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co - operation and Development, Guideline-423 
[65]
. 
The experimental protocol was approved by the institutional ethical committee 
(IAEC) under CPCSEA (IAEC no: IAEC/XLVIII/11/CLBMCP/2016). 
These studies were conducted in C.L. Baid Metha College of Pharmacy, 
Dhuraipakkam, Chennai.
 
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity of 
the test substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
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 The acute toxic class method is based on biometric evaluations with fixed doses, 
adequately separated to enable a substance to be ranked for classification 
purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
Principle of the Test:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. 
Absence or presence of compound-related mortality of the animals dosed at one step 
will determine the next step, i.e. 
- no further testing is needed 
- dosing of three additional animals, with the same dose  
- dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance 
to one of a series of toxicity classes. 
Methodology: 
Selection of Animal Species  
 The preferred rodent species is the wistar albino rat, although other rodent 
species may be used. Healthy young adult animals are commonly used laboratory 
strains should be employed. Females should be nulliparous and non-pregnant. Each 
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animal, at the commencement of its dosing, should be between 6 to 8 weeks old and the 
weight (150-200gm) should fall in an interval within±20 % of the mean weight of any 
previously dosed animals.  
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hours light, 12 hours dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals may 
be group-caged by dose, but the number of animals per cage must not interfere with 
clear observations of each animal. 
Preparation of animals: 
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions. 
Test Animals and Test Conditions: Sexually mature Female Wistar albino rats (150-
200gm) were obtained from Kings institute, Guindy, Chennai. All the animals were kept 
under standard environmental condition (22±3°C).  The animals had free access to 
water and standard pellet diet (Sai meera foods, Bangalore). 
Preparation of animals:   
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions. 
Preparation for Acute Toxicity Studies 
 Rats were deprived of food overnight (but not water 16-18 hr) prior to 
administration of the, Munthirikai Choornam. 
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
Test Substance  :  MUNTHIRIKAI CHOORNAM 
Animal Source  :  Kings institute, Guindy, Chennai 
Animals   :  Wister Albino Rats (Female-3+3) 
Age    :   6-8 weeks 
Body Weight on Day 0 :  150-200gm. 
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Acclimatization  :  Seven days prior to dosing. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :  By cage number, animal number and individual   
      marking by using Picric acid. 
Number of animals  :  3 Female/group,  
Route of administration :  Oral  
Diet                        : Pellet feed supplied by Sai meera foods Pvt     Ltd,   
Banglore.  
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
       provided with bedding of husk. 
Housing temperature :  between 22ºC + 3ºC.  
Relative humidity  :  between 30% and 70%, 
Air changes    :  10 to 15 per hour and  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  14 Days 
Administration of Doses:  
 Munthirikai Choornam was suspended in water and administered to the groups 
of wistar albino rats in a single oral dose by gavage using a feeding needle. The control 
group received an equal volume of the vehicle. Animals were fasted 12 hours prior to 
dosing. Following the period of fasting, the animals were weighed and then the test 
substance was administered. Three Female animals are used for each group. The dose 
level of 5, 50, 300and 2000 mg/kg body weight was administered stepwise. After the 
substance has been administered, food was withheld for a further 3-4 hours. The 
principle of laboratory animal care was followed. Observations were made and recorded 
systematically and continuously as per the guideline after substance administration. The 
visual observations included skin changes, mobility, aggressively, sensitivity to sound 
and pain, as well as respiratory movements. Finally, the number of survivors was noted 
after 24 hrs and these animals were then monitored for a further 14 days and 
observations made daily. The toxicological effect was assessed on the basis of 
mortality. 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
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first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead. It should be determined by the toxic reactions, time of onset and length of 
recovery period, and may thus be extended when considered necessary. The times at 
which signs of toxicity appear and disappear are important, especially if there is a 
tendency for toxic signs to be delayed. All observations are systematically recorded 
with individual records being maintained for each animal. 
Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarized in the Humane Endpoints Guidance Document taken into consideration. 
Animals found in a moribund condition and animals showing severe pain or enduring 
signs of severe distress was humanly killed. When animals are killed for human reasons 
or found dead, the time of death was recorded 
[66]
. 
4.3.2 REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF Munthirikai 
CHOORANAM ON RATS – (OECD-407 guidelines)[67] 
Test Substance  :  Munthirikai Choornam 
Animal Source  :  Kings institute, Guindy, Chennai 
Animals   :  Wister Albino Rats (Male -24, and Female-24) 
Age    :  6-8 weeks 
Body Weight    :  150-200gm. 
Acclimatization  :  Seven days prior to dose. 
Veterinary examination :  Prior and at the end of the acclimatization period. 
Identification of animals :  By cage number, animal number   and    individual  
    marking by using    Picric acid 
Diet    :  Pellet feed supplied by Sai Meera Foods Pvt Ltd,   
       Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
        provided with bedding of husk. 
Housing temperature :  between 22ºC±3ºC.  
Relative humidity  :  between 30% and 70%, 
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Air changes    :  10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 28 Days. 
Table 8 
 
 
 
 
 
 
MC-MUNTHIRIKAI CHOORNAM 
Methodology 
Randomization, Numbering and Grouping of Animals: 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consist of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three group were treated with test drug (low, mid, high) for 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior to 
the initiation of treatment. Each animal was marked with picric acid. The females were 
nulliparous and non-pregnant. 
Justification for Dose Selection: 
         As per OECD guideline three dose levels were selected for the study. They are 
low dose (X), mid dose (5X), high dose (10X). X is calculated by multiplying the acute 
toxicity dose 2000mg) and the body surface area of the rat (0.018). i.e X dose is 
(30mg/kg), 5X dose is (150mg/kg), 10X dose is (300mg/kg). 
Preparation and Administration of Dose: 
Munthirikai Chooranam  suspended in with water, It was administered to 
animals at the dose levels of X, 5X, 10X. The test substance suspensions were freshly 
prepared every two days once for 28 days. The control animals were administered 
vehicle only. The drug was administered orally by using oral gavage once daily for 28 
consecutive days. 
Observations: 
Experimental animals were kept under observation throughout the course of study 
for the following: 
Body Weight:  Weight of each rat was recorded on day 0, at weekly intervals 
Groups No of Rats 
Group I Vehicle control (Water) 12(6male,6 female) 
Group II MC- low dose X (30mg) 12 (6male,6 female) 
Group III MC- Mid dose 5X (150mg) 12 (6male,6female) 
Group IV MC- High dose 10X(300mg) 12(6male,6female) 
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throughout the course of study. 
Food and water Consumption:  Food and water consumed per animal was calculated 
for control and the treated dose groups.  
Clinical signs:  All animals were observed daily for clinical signs. The time of onset, 
intensity and duration of these symptoms, if any, were recorded. 
Mortality: All animals were observed twice daily for mortality during entire course of      
study. 
Necropsy:  All the animals were sacrificed by excessive anaesthesia on day 29. 
Necropsy of all animals was carried out. 
Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Hematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
Haematological Investigations: 
Haematological parameters were determined using Haematology analyzer.  
Biochemical Investigations:  
Biochemical parameters were determined using auto-analyzer. 
Histopathology:  
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low, then the mid dose group will also be examined. Organs will be collected 
from all animals and preserved in 10% buffered neutral formalin for 24 h and washed in 
running water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an 
auto technic on and then cleared in benzene to remove absolute alcohol. Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed 
by microtome and the slides were stained with Haematoxylin-eosin red. 
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Statistical analysis:  
Findings such as body weight changes, water and food consumption, 
hematology and blood chemistry were subjected to One-way ANOVA followed by 
dunnett test using a computer software programme – Graph pad version7.  
4.4 PHARMACOLOGICAL STUDIES 
4.4.1 ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM IN     
SPOTANEOUSLY HYPERTENSIVE RATS 
Cardiovascular disease is a leading cause of death, and hypertension is a critical 
risk factor for cardiovascular events. The pathogenesis of hypertension is accompanied 
by decreased nitric oxide (NO) bioavailability in the vasculature and increased 
cardiovascular remodelling. Hypertensive patients frequently develop clinically evident 
cardiac hypertrophy 10 to 20 years after the onset of hypertension, as a result of 
adaptive and maladaptive responses to pressure overload. Cardiac hypertrophy has been 
linked to the development of a variety of cardiovascular diseases, including myocardial 
ischemia, arrhythmias, and sudden cardiac death. Therefore, treatment options that not 
only maintain stable pressure levels but also delay or even regress the structural and 
functional changes in resistance arteries and the heart are needed. Despite the current 
availability of multiple anti-hypertensive medication types, a significant number of 
patients do not respond to treatment and remain hypertensive. As multiple mechanisms 
likely contribute to the development of hypertension, including angiotensin, oxidative 
stress and hemodynamic changes, multi-targeted therapeutic interventions will likely be 
required for effective management of hypertension. 
Animals:  
All animal experiments were performed in accordance with the Guidelines of 
OECD. All experiments were performed with the approval of IAEC of C.L. BAID 
METHA COLLEGE OF PHARMACY. SHR (9 weeks old) and age-matched Wistar 
rats male, weighing 250±20 g, were purchased from King Institute of Preventive 
Medicine and Research, Rats were kept in a room temperature controlled room (25 °C), 
with 12 hours dark and 12 hours artificial illumination daily (7:00— 19:00). Food and 
water were available ad libitum. 
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GROUPING 
The animals were divided into following groups: 
 Group 1 control untreated group which received normal saline.  
 Group 2 received Verapamil 12.5 mg/kg b.w 
 Group 3 MC100 mg/kg b.w 
 Group 4 MC200mg/kg b.w 
The drug MC was administered orally and once daily for 4 weeks. 
In this study, the effect of a four weeks chronic administration of daily oral doses of 100 
and 200 mg/kg body weight, MC on blood pressure was measured. 
 The stock solution was prepared once every three days. Extract suspensions were stored 
at 4ºC and were allowed to reach room temperature before administration. 
METHOD: 
Systolic blood pressure (SBP) and heart rate measurement of SH rats was 
carried out using tail-cuff method plethysmography (LE 5001 Pressure Meter).A mean 
of six measurements was obtained for each animal. For blood pressure measurement, 
the animals were warmed up to 42°C for 5 min in a confinement cage. The animals were 
first submitted to a period of adaptation for 15 days before the experiments and only 
SHR with an SBP > 170 mmHg were selected for this study.  
During the final week of the treatment, the rats were allowed to acclimatize to 
the experimental conditions of non invasive SBP measurements by allowing them to 
stand in rat restrainers for 30 min every day. SBP measurements were recorded 24 hours 
after the last treatment dose. At least 8-10 recordings were taken for each rat and the 
mean of the lowest 4 values within less than 10 mmHg difference was taken as the 
mean SBP 
[68]
. 
4.4.2 DIURETIC ACTIVITY OF MUNTHIRIKAI CHOORANAM 
The method of Lipchitz et al [69] was employed for the assessment of diuretic 
activity . 
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EXPERIMENTAL ANIMAL 
 The animal model for diuretic was wistar albino rats of either sex. 
 The weight of animals range from 150-180 gms 
 The animals were housed in polypropylene cages maintained under standard 
conditions that was 12 hours light/dark cycle, 25±30˚c, 35-60% relative 
humidity. 
 All the rats were fed with standard raw chow and water ad libitum.  
 Initially for the assessment of diuretic activity, the urine output, sodium, 
potassium and chloride levels in urine of each animal were measured. 
STUDY OF THE DIURETIC ACTIVITY 
 The animals are segregated into four groups of six animals each. 
 The animals are deprived of food and water for 15 hours prior to the 
experiment. 
 Before the oral administration of the test drug the animals were hydrated 
with normal saline 20ml/kg administrated orally through a pediatric 
nasogastric tube 
[70]
 .
 
EXPERIMENTAL DESIGN
 
 Group I     - normal water serves and as the control group. 
 Group II  - treated with standard diuretic drug furosemide of 20mg/kg of     
body weight serves as the standard group. 
 Group III - treated with test drug MC100mg/kg body weight suspended 2ml 
of water serves as the test group low dose. 
 Group IV - treated with test drug MC200mg/kg body weight suspended 
with2ml of water serves as the test group high dose. 
Immediately after administration of the test drugs, the animal were placed in 
fabricated metabolic cages individually to allow separation of urine and faeces. The 
bottom of metabolic cages was fixed with a glass funnel and the stem of the funnel was 
inserted in a measuring cylinder containing mineral oil. The presence of mineral oil in 
the measuring cylinder prevents loss of urine through evaporation. The urine was 
collected for 5
th
 hour and 24
th
 hour after administration control, standard and test drug. 
The bladder was emptied by pull the base of tail of each rat[71][72] . 
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OBSERVATION 
 Animals are subjected to collect urine periodically by metabolic cages. 
 Diuretic assay parameters were observed for each rat. 
 The total volume of urine was measured. 
 Urinary pH, urinary sodium excretion, urinary potassium excretion, 
urinary chloride excretions are determined. The concentration  of 
sodium, pottassium and chloride levels excreted  in the urine were 
measured by flame photometry
[73]
 and the chloride concentration was 
estimated by titration with silver nitrate solution(N/50) using 3 drops of 
5% potassium chromate as indicator 
[74]
 
 The data was analysed using one way analysis of variance (ANOVA). 
 The statistical significance of the difference of the means was evaluated 
by Dunnet’s multiple comparison test 
4.4.3 ANTI-OXIDANT ACTIVITY OF MUNTHIRIKAI CHOORANAM 
         DPPH ASSAY (2, 2-diphenyl -1-picrylhydrazyl)  in  IN-VITRO 
     The radical scavenging activity of different extracts was determined by using 
DPPH assay according to 
[75]
 Chang et al[2001].The decrease in the absorption of the 
DPPH solution after the addition of an antioxidant was measured at 517 nm. 
Ascorbic acid (10mg/ml DMSO) was used as reference. 
PRINCIPLE  
1,1-diphenyl-2-picryl hydrazyl is a stable free radical with red colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free radical 
scavenging activity. The scavenging reaction between (DPPH) and an antioxidant (H-A) 
can be written as,  
DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence the 
absorbance decreases. The degree of discoloration indicates the scavenging potential of 
the antioxidant compounds or extracts in terms of hydrogen donating ability. 
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REAGENT PREPARATION 
0.1mm DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
PROCEDURE 
Different volumes (1.25-20µg/µl) of MC extracts were made upto 40µl with 
DMSO and 2.96ml DPPH (0.1mM) solution was added. There action mixture was 
incubated in dark condition at room temperature for 20min. After 20min, the absorbance 
of the mixture was read at 517 nm. 3ml of DPPH was taken as control. The % radical 
scavenging activity of the MC extracts was calculated using the following formula, 
       Control-Test 
% inhibition =            × 100 
           Control 
Ingredients of  Munthirikai Chooranam                              
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Fig 1. 7 Piper longum                                                            Fig 1.8  Glycyrrhiza glabra                                                      
 
 
 
 
 
           
 
   Fig 1.9 Plectranthus veetiveroides                                              Fig 1.10Mesua nagassarium                                                                     
                                               
                                                   
 
                                                                                                                                                                                                                                                                                                                                 
 
 
      Fig 1.11Cyperus rotandus             Fig 1.12Borneo camphor 
 
                                                                                                       
                                                                                                                          
                                              
                                                                                                                 
 
               
 
                                                                                                                                                                                                                                                         
                                                  
                                         
Fig 1.13 Terminalia chebula                            Fig 1.14Phyllanthus emblica  
     
 
                                        
 
                                    
 
 
Fig1.15Terminalia chebula    Fig 1.16 Aegle marmelos 
 
 
 
 
 
 
 
Fig 1.17 Oryza sativa      Fig 1.18 Santalum album 
 
 
 
  
 
 
 
 
 
Fig 1.19 Cinnamomum tamla    Fig 1.20 Root of Piper longum 
 
 
 
 
 
 
 
Fig 1.21 Phoenix dactylifera     Fig 1.22 Rock candy 
     
 
 
 
 
 
 
 
Fig 1.23 Maranta arundinacea   Fig 1.24 Eletaria cardamom 
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               Fig.No .2  A & B Shows  preparation of Munthirikai Chooranam 
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5. RESULTS AND DISCUSSION 
            Many studies have been carried out to bring the efficacy and potency of the drug 
“Munthirikai Chooranam”. The study includes Literary Collections, Organoleptic 
Characters, Physicochemical Analysis, Phytochemical Analysis, Acid-Base radical test, 
Bacterial load, Instrumental Analysis, Toxicological Study and Pharmacological Study. 
The drug “Munthirikai Chooranam” has been selected for Anti-Hypertensive activity 
in reference with the text “Aathma Ratchamirtha Vaithiya Saara Sangiragam”. pg no: 
206. 
 Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug state the evidence and importance of its utility in 
treating the hypertension. 
 Botanical aspect explains the identification, description, active principle and 
medicinal uses of the plants. 
 Gunapadam review brings the effectiveness of the drug in treating 
hypertension. 
 Pharmaceutical review describes about the Chooranam and its properties. 
 The pharmacological review explains about the methodology of Anti- 
Hypertensive Activity and the drugs used. Modern and Siddha aspect of the 
disease was also reviewed. 
STANDARDISATION OF THE TEST DRUG   
Standardization of the drug is more essential to derive the efficacy, potency of 
the drug by analyzing it by various studies. Following are the results of 
physicochemical and  phytochemical analysis. Physical characterization and estimation 
of basic and acidic radicals have been done and tabulated. Toxicological results of the 
drug and pharmacological activity of the drug were derived. Its result has been tabulated 
and interpretation is given below. Thus it is to give a complete justification to bring the 
effectiveness in treating hypertension of the trial drug “Munthirikai chooranam”. 
Siddha parameters of testing for Chooranam, 
 Chooranam tends to be amorphous. 
 It should never be damp.                                                           
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 The fineness of the sieve should be number 100 mesh or still finer and 
the Chooranam gave the inference of amorphous and not damp. 
ORGANOLEPTIC CHARACTERS 
The following characters have been noted in Munthirikai Chooranam. 
                         Table No.9. Organoleptic Characters 
 
  
    
 
 
 
 
       Table No.10. Physicochemical Analysis 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Colour Brown 
Odour Pleasant 
Taste Bitter 
Texture Fine powder 
Particle size Completely  pass  
through sieve no 88 
S. No Parameter        Result 
1. Ph           5.02 
2. Total Ash (%)           5.33 
3. Water soluble Ash (%)           3.45 
4. Acid insoluble Ash (%)           1.20 
5. Loss on drying (%)           8.00 
6. Solubility  
 i. Distilled water        Soluble 
 ii. Benzene        Soluble 
 iii. Chloroform        Soluble 
 iv. Carbon tetra chloride        Soluble 
 v. Xylene        Soluble 
 vi. Petroleum ether        Soluble 
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Interpretation 
 The physicochemical analysis of the drug result reveals the pH, Moisture, 
Solubility, Water soluble ash and Acid insoluble ash. 
 pH:  It is a measure of hydrogen ion concentration; i.e., acidic or alkaline in 
nature. 7.0 is a neutral, above 7.0 is  alkaline and below are acidic. The pH of the 
drug “Munthirikai  Chooranam” is 5.02 which is acidic in nature. In acidic 
medium these acidic drugs are better absorbed from the stomach and increases 
the bioavailability and effectiveness [76]. 
 Ash: Ash constitutes the inorganic residues obtained after complete  combustion 
of a drug. Thus Ash value is a valid parameter to describe and to assess the 
degree of purity of a given drug. Total Ash value will determine the amount of 
minerals and earthy material present in the drug. The total value of MC is 5.33 
which determine the absence of inorganic content. 
 Acid insoluble ash: The acid insoluble ash value of the drug denotes the amount 
of siliceous matter present in the sample. The quality of the drug is better if the 
acid insoluble value is low. It is 1.20 for MC. 
 Water soluble ash: Water-soluble ash is the part of the total ash content, which 
is soluble in water. It is 3.45 for MC. 
 Loss on drying: The moisture present in the drug was established in loss on 
drying. The moisture content of the drug reveals the stability and its shelf-life. 
High moisture content can adversely affect the active ingredient of the drug. 
Thus low moisture content could get maximum stability and better shelf life. 
Loss on drying of MC is 8.00
[77]
. 
           Phytochemical Analysis 
       Table No. 11. Phytochemical screening test 
Phytochemical Test 
 MC Aqueous extract 
           Alkaloid Present 
         Glycosides Present 
           Saponin Absent 
       Carbohydrate Absent 
         Phytosterol Absent 
            Phenol Present 
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Interpretation 
Phytochemicals are natural bioactive compounds, found in plants and fibers, which act 
as a defense system against diseases and more accurately protects the body against 
diseases. The phytochemical analysis reveals that the presence of Alkaloids, Glycosides, 
Phenol, Triterpene, Flavanoids and Quinones
[78]
. 
Alkaloids 
 Alkaloids possess Vasodilator and anti-arrhythmic effects 
 Alkaloids are the active principles producing many essential effects in protecting 
the body 
[79]. 
Glycosides 
 They also protect heart from complications 
 They possess Anti-oxidant activity [80]. 
Phenols
 
 They possess rich Anti-Oxidant property and protect body from oxidative 
stress
[81]
.
 
 Phenol groups are the essential part of many anti-oxidant compounds. 
Triterpenes 
 The triterpenes are the best immunomodulators and also have anti-oxidant 
property. 
 They possess vasodilator, endothelial protection effect and anti-arrhythmic 
effect [82
]
. 
Flavonoids 
 It is the most important group of polyphenol compounds in plants. 
 They improve the endothelial and capillary function. 
 Reduces the risk of atherosclerosis. 
 They  help in strengthening and protect the inner lining of blood vessels 
   Phytochemical Test 
MC Aqueous extract 
         Triterpene Present 
         Flavonoid Present 
          Quinone Present 
           Protein Present 
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 Flavonoids are a group of plant metabolites which provide health benefits 
through cell signaling pathways and antioxidant effects. 
 Flavonoids can exert their Anti-Oxidant activity by scavenging the free radicals, 
by chelating metal ions or by inhibiting enzymatic systems which are 
responsible for free radical generation[83]. 
Quinones 
 Quinone possesses anti-oxidant activity. 
 Prevent cardiovascular diseases [84]. 
Protein 
 They help in repairing cells and important for growth [85]. 
 A synergistic effect of all these alkaloids, glycosides, phenols, triterpenes, 
flavanoids, quinones   increases the potency of the drug against hypertension. 
 
TLC/HPTLC analysis of chloroform extract of  MC 
HPTLC analysis 
Chloroform extract was applied in TLC aluminum sheet silica gel 60 (E. 
MERCK) and the plate was developed using the solvent system Toluene: Ethyl acetate 
(9:1).After development, the plate is allowed to dry in air and examined under UV - 
254nm, 366 nm and visible light (Vanillin - Sulphuric acid) 
      
 
 
 
 
 
  = 254 nm    = 366 nm  
 
=520nm 
(Derivatized) 
 
                          Fig.No.6.1. HPTLC plates of Chloroform Extracts 
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    Table no :12 Rf Values for Chloroform Extract 
 
   3D Chromatogram at 254 nm: 
 
                        
   Graph.No.1. 3D Chromatogram 
 
    
 
 
 
Color Rf value(s) Color Rf  value(s) Color Rf value(s) 
Green 0.04 Sky Blue 0.03 Violet 0.07 
Green 0.08 Green 0.05 Green 0.12 
Green 0.11 Sky Blue 0.08 Indigo 0.15 
Green 0.22 Sky Blue 0.11 Violet 0.28 
Green 0.29 Red 0.24 Violet 0.38 
Green 0.34 Red 0.32 Violet 0.48 
Green 0.50 Red 0.35 Dark 0.60 
Green 0.65 Sky Blue 0.40 Violet 0.75 
Green 0.69 Red 0.43   
  Red 0.58   
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HPTLC finger print analysis for chloroform extract of MC 
  The finger print chromatogram was recorded at 254 nm. It showed 13 peaks of 
which peaks at Rf. And two were the major peaks and others were moderately smaller 
peaks. 
 
  
 
            Graph.No.2. HPTLC finger print for chloroform extract of MC 
            Peak Table at 254 nm 
 
Table no.13.Chloroform extracts - Rf values in HPTLC finger print 
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Interpretation: 
 The quantitative estimation of compounds present in the MC has been performed 
by HPTLC. The method may be applied to identify the MC from other 
manufacturing process. 
 They provide the identification of constituents, determination of impurities and 
quantitative determination of active substance present in the MC 
[86]
. 
 The Rf value of the MC observed through these findings supports the better 
standardization of the drug. 
 The present study revealed that MC showed best results in Toluene: Ethyl 
acetate (9:1). Solvent system. After scanning and visualizing the plates in 
absorbance mode at both 254 nm, 366 nm and visible light range, best results 
were shown at visible light range. 
 TLC plate showed different colour, phytoconstituents of chloroform extract of 
MC. The bands revealed the presence of eleven greenish, four sky blue, five red, 
five violet, one indigo band showing the presence of alkaloids, glycosides, 
phenols, triterpenes, flavanoids, quinines. 
 HPTLC study as recommended in this study provides a chromatographic 
fingerprint of phytochemicals and is suitable for confirming the identity and 
purity of medicinal plant raw material. 
 The results from HPTLC finger print scanned for chloroform extract of MC. 
There are thirteen polyvalent phytoconstituents and corresponding ascending 
order of Rf values start from 0.00 to 0.94 in which highest concentrations of the 
phytoconstituents was found to be 23.06% and 15.97 % with its corresponding 
Rf value were found to be 0.10 and 0.26 respectively. 
BIO CHEMICAL ANALYSIS 
        Table.No.14 Results of basic radicals studies of MC 
 
S.No Parameter Observation Result 
1. Test for Potassium Formation of yellow  colour 
precipitate 
Positive 
 
2. Test for Calcium 
 
Formation of white colour 
precipitate 
Positive 
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S.No Parameter Observation Result 
3. Test For Magnesium Formation of white colour 
precipitate 
Positive 
4. Test For Sodium Appearance of intense yellow  
colour 
Positive 
5. Test for Iron  
(Ferrous) 
Appearance of blood red colour Positive 
 
6. Test For Zinc 
 
Formation of white colour 
precipitate 
Positive 
 
Interpretation 
The results of basic radical test shows that the presence of Potassium, 
Magnesium, Calcium,Iron, Zinc, Sodium and absence of heavy metals such as lead, 
arsenic and mercury. 
Potassium 
 Potassium is important for muscle function especially relaxing the wall of blood 
vessels. 
 This lowers the blood pressure and protects against muscle cramps. 
 This protects against irregular heart beat. 
Magnesium 
 Magnesium also helps in regulation of blood pressure and relaxing the blood 
vessels 
Calcium 
 Calcium is important for healthy blood pressure because it helps in 
vasoconstriction and vasodilatation of blood vessels 
[87]
.
 
Sodium 
 Sodium also important for regulation of blood pressure 
Iron 
 Iron helps in regulation of blood pressure 
 Iron is essential for proper functioning of immune system [88]. 
Zinc 
 Zinc have an Anti-oxidant property 
 Helps to protect cells in the body from damage caused by free radicals[89] 
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     Table no.15.Results of acid radical studies
 
  
Interpretation 
The acidic radicals test shows the presence of  Sulphate, Chloride, and Nitrate. 
Chloride 
 They helps in maintenance of proper blood volume, blood pressure, pH of blood 
and also helps in balance between ECF and ICF of cells [90].
 
Sulphate 
 Nitric oxide derived from nitrate, which helps in reduction of blood pressure by 
the vasodilatation of blood vessels [91].
 
 
Table no.16.Availability of Microbial  load in MC 
 
      MICROBES 
 
     DILUTION 
 
     RESULT 
 
BACTERIA 
 
10
-4 
 
7 
 
BACTERIA 
 
10
-6 
 
5 
 
FUNGI 
 
10
-2 
 
4 
 
FUNGI 
 
10
-3 
 
2 
 
Interpretation 
 The availability of bacterial load in the MC has been performed by Plate count- 
Agar plate technique. 
S.NO Parameter Observation Result 
1. Test for Sulphate Formation of white 
precipitate 
Positive 
2. Test for Chloride Formation of white 
precipitate 
Positive 
                                                                                                                          RESULTS AND DISCUSSION 
 
ANTI-HYPERTENSIVE ACTIVITY OF MUNTHIRIKAI CHOORANAM 125 
 
 MC is a herbo-mineral drug prepared by plants and mineral. It is easy to get 
contamination if any contamination present in drug that decreases the potency 
and efficacy. 
The contamination of MC has been examined by bacterial and fungal load. 
Total bacterial load in 10
-4 
dilution is 7and 10
-6 
dilution is 5 
Total fungal load in 10
-2 
dilution is 4 and 10
-3
 dilution is   2 
Here, the result shows presence of bacterial and fungal load in the trial drug 
(MC). They present within the normal limits. 
 
INSTRUMENTAL ANALYSIS 
FT-IR (Fourier Transform Infra Red spectroscopy) 
Fourier Transform Infra-Red Spectroscopy (FTIR) analysis results in absorption 
spectra provide information about the functional group and molecular structure of a 
material. The results of Table no.17 and Graph no. 3  shows the presence of functional 
group and inorganic compounds of MC 
 
 
 
Graph.no.3.FT-IR (Fourier Transform Infra Red) 
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  Table no: 17 FTIR spectra of MC 
 
 
FTIR Interpretation of MC 
In the FT-IR Spectra analysis, this  MC exhibits the peak value shows in at the 
wave number of  3370, 2971, 2933, 2885, 2658, 1650, 1466, 1410, 1380, 1341, 1307, 
1161, 1129, 1000, 952, 817,668  having C=H Stretch, C=O amide, C=O Stretch, C-H 
bend, C-N Stretch, C-O Stretch, =C-H bending, C-Cl Stretch. This indicates the 
presence of some organic functional groups such as alcohol, alkane, acid, alkyl halide, 
amine, alkenes. The alkyl halide group is found in this sample predominantly.  
 
 
 
 
 
 
Sl.No 
 
Wave number (cm-1) 
Vibrational modes 
of MC in IR region 
 
Functional group 
1 3370 N-H stretch 1
o
,2
o
 amines, amides 
2 2971 C-H Stretch Alkanes 
3 2933 C-H Stretch Alkanes 
4 2885 C-H Stretch Alkanes 
5 2658 H-C=O:C-H Aldehydes 
6 1650 C=O stretch Acarbonyls 
7 1466 C-H bend Alkanes 
8 1410 C-H  bend Alkanes 
9 1380 C-F rock Alkanes 
10 1341 C-F rock Alkanes 
11 1307 C-O Stretch Alcohols, carboxylicacids 
12 1161 C-N Stretch Aliphatic amines 
13 1129 C-N Stretch Aliphatic amines 
14 1000 =C-H bend Alkenes 
15 952 O-H bend Alkenes 
16 817 C-Cl Stretch Alkyl halide 
17 668 C-Cl Stretch Alkyl halide 
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SEM (SCANNING ELECTRON MICROSCOPE)
 
 
  
     
Fig No :7 SEM images of MC 
 
The particle morphology can be identified through these SEM images of Siddha 
medicine Munthirikai chooranam. The particles are not spherical in shape. The size of 
the particles was approximately identified between 1 to 3 μm[92]. 
 
XRD: 
                         
           Graph no.4 XRD image of MC 
Interpretation 
 The structure, the size and shape of the particles are highly dependent on the 
route of synthesis and high lights the efficacy of the drug. The micro particles may 
enhance bio absorption of the drug. 
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 The major diffraction peaks are identified after XRD analysis MC concluded 
that range nm is association with organic molecules probably plays an important role in 
making in biocompatible and nontoxic at therapeutic doses. Other elements present in 
MC act as additional supplement and possibly helps in increase the efficacy of the 
formulation 
[93]
. 
 
ICP-OES (Inductively Coupled Plasma Optical Emission Spectroscopy): 
The drug sample MC was analysed by the Inductively Coupled Plasma Optical 
Emission Spectroscopy (ICP-OES) to detect the trace elements  and other elements 
quantitatively. The result of ICP-OES is given on the  
                           
                      Table No.18. ICP-OES findings of MC  
S. no Elements Detected levels 
1. Aluminium BDL 
2. Arsenic BDL 
3. Calcium 02.170 mg/L 
4. Cadmium BDL 
5. Copper BDL 
6. Iron 05.316 mg/L 
7. Mercury BDL 
8. Potassium 53.401 mg/L 
9. Magnesium 01.384 mg/L 
10. Sodium 14.710 mg/L 
11. Nickel BDL 
12. Lead BDL 
13. Phosphorus 78.341 mg/L 
14. Sulfur 01.304 mg/L 
 
BDL:Below Detectable Limit 
1% = 10000ppm, 
1ppm = 1/1000000 or 1ppm = 0.0001% 
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    Table no.19 The toxic metals and the permissible limits 
Heavy metals WHO & FDA limits 
Arsenic (As) 3ppm 
Mercury (Hg) 1ppm 
Lead (Pb) 10ppm 
Cadmium (Cd) 0.30ppm 
 
Interpretation : 
The amount of presence of metals in Siddha herbo-mineral formulation MC was 
estimated through ICP-OES analysis study and their range is mentioned here. The 
presence of major heavy metal such as Mercury, arsenic, cadmium, Lead were 
identified as BDL which means their presence in the test drug is within the WHO 
permissible limits. So, the drug may be considered as safe for therapeutic use. 
 
TOXICITY STUDY  
Acute oral toxicity study of MC 
Wistar albino rat was treated with the test drug Munthirikai Chooranam of 
single dose of 2000mg/kg in 2%CMC as suspention. This study was conducted as per 
the OECD guidelines. The result of acute toxicity of MC has been tabulated below. 
 
Table 20: Dose finding experiment and its behavioral Signs of acute oral toxicity 
Observation done 
S.No Control Group Observation S.No Test Group Observation 
1 Body weight Normal 1 Body weight 
Normally increased 
 
2 
Assessments of 
 Posture 
Normal 2 
Assessments of 
posture 
Normal 
3 
Signs of Convulsion 
Limb paralysis 
Normal 3 
Signs of Convulsion 
Limb paralysis 
Absence of sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
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S.No Control Group Observation S.No Test Group Observation 
6 Salivation Normal 6 Salivation Absence 
7 
Change in skin 
 Color 
No significant 
color change 
7 
Change in skin 
color 
No significant color 
change 
8 Piloerection Normal 8 Pilo erection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 Sensitivity response Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
 
     Table 21 (Observational study Results) 
 
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - - - 
2. 2000mg 
 
+ - - + - + - - - - - - - - - - - - - - 
 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping   
6.Touch Response 7. Decreased Motor Activity 8. Tremors 9.  Convulsions 10. 
Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing  
19. Respiration 20. Mortality. 
(+  Present, -  Absent) 
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Table 22 ( Body weight Observation) 
 
 
 
 
 
 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D            
(One-way ANOVA followed by Dunnett’s test) 
 
 
        Table No.23. Water intake (ml/day) of wistar albino rats group exposed to MC 
 
 
      DOSE 
 
DAYS 
1 6 14 
CONTROL 60 ± 1.62 60±1.10 60.1±1.04 
HIGH DOSE 59.5±1.04 59.5±2.07 59.8±2.04 
 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-way 
ANOVA followed by Dunnett’s test) 
 
         Table No.24. Food intake (gm/day) of wistar albino rats group exposed to MC 
 
 
DOSE 
 
DAYS 
1 7 14 
CONTROL 62.4±1.54 62.2±1.62 62.7±4.06 
HIGH DOSE 64.0±2.24 64.4±2.10 64.6±2.70 
 
N.S- Not Significant,**(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One-way 
ANOVA followed by Dunnett’s test 
DOSE 
 
DAYS 
1 7 14 
CONTROL 270.1±65.70 270.7± 09.71 270.6 ±2.10 
HIGH DOSE 260.3± 4.44 260.4 ±7.12 260.2 ± 6.05 
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Interpretation 
The results of acute toxicity studies shows the effect of drugs on different organ 
and system. The trial drug MC was given at the increasing dose level of 5mg, 50mg, 
300mg, 2000mg in rats through oral administration.  
There is no abnormal behavioural changes were observed. No mortality is seen. 
So can conclude there is no toxicity findings at the acute toxicity level determination. 
Based on OECD 423 the trail drug MC is considered non toxic up to the dose of 
2000mg/kg.    
  Repeated Dose 28-Days Oral Toxicity (407) Study of MC 
 
  Table No.25. Body weight of Wistar albino rats group exposed to MC 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
 
        
 
 
 
 
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 282.2±05.64 282.2±10.04 282.4 ± 12.40 282.4±14.40 282.2 ± 12.10 
LOWDOSE 280.7 ±57.75 279.4 ±4.19 281.3± 5.21 282 ±1.40 281.6± 6.16 
MID DOSE 281.1± 1.22 280.2 ± 2.21 279.2± 1.42 280.2 ± 5.08 279.4 ± 13.12 
HIGHDOSE 272.2± 2.41 273.4±3.17 274.8 ± 2.64 275.2 ± 4.18 276 ± 3.30 
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       Table No.26. Water intake (ml/day) of Wistar albino rats group exposed to MC 
 
DOSE 
 
DAYS 
1 6 14 21 28 
CONTROL 56.4 ±2.34 56.2±1.07 56.7±1.30 56.8±1.10 56.4±1.70 
LOW DOSE 63.6±1.81 63.6±2.43 63.6±1.72 63.7±2.36 63.7±1.30 
MID DOSE 64.2±2.21 64.2±1.21 64.1±2.52 64.4±1.42 64.4±1.74 
HIGH DOSE 58.2±3.40 58.2±1.42 58.4±1.44 58.6±1.78 58.8±2.62 
        N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
 
        Table No. 27 Food intake (gm/day) of Wistar albino rats group exposed to MC 
 
DOSE 
 
DAYS 
2 7 23 22 28 
CONTROL 61±3.01 61.2±2.11 61.4±3.11 61.4.2±3.42 61±3.40 
LOWDOSE 59.5±7.12 59.5±1.44 59.6±1.50 59.4±1.20 59.8±1.92 
 MID DOSE 60.2±6.70 60.2±2.20 60.6±2.24 60.6±1.46 60.7±1.74 
HIGHDOSE 64.3±1.55 64.6±1.54 64.8±2.16 65.1±1.50 65.1±1.72 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test 
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Table No.28. Hematological parameters of  wistar albino rats group expose to MC 
        **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
    
Table No.29. Biochemical Parameters of Wistar albino rats group exposed 
to MC 
 
BIOCHEMICAL 
PARAMETERS 
CONTOL LOW DOSE MID DOSE HIGH DOSE 
GLUCOSE (R) (mg/dl) 85.10±1.22 85.13±1.31 85.6±.04 85.7±6.20 
   T.Cholesterol(mg/dl) 105.10±3.10 98.15±2.20 96.10±1.17
* 
91.11±13
** 
TGC(mg/dl) 76.03±1.4 74.04±1.32 72.05±1.32
** 
69.06±1.04
* 
LDL 69.2±4.13 68.4±1.45 66.3±1.23 62.4±2.22
** 
VLDL 14.6±1.30 14.6±1.42 14.6±1.22 14.4±1.24 
Category Control Low dose Mid dose High dose 
Haemoglobin(g/dl) 34.6±0.43 34.1±0.30 36.6±0.13 37.6±0.23 
Total WBC (×10
3  
l) 9.1±0.40 9.12±0.01 9.1±0.08 9.13±1.30 
Neutrophils (%) 15.1±0.20 15.12±0.23 15.13±1.06 15.14±1.07 
Lymphocyte (%) 80.10±1.36 80.10±1.20 80.12±1.24 81.20±1.34 
Monocyte (%) 0.01±0.02 0.01±0.01 0.01±0.04 0.01±0.03 
Eosinophil (%) 0.04±0.06 0.04±0.03 0.04±0.05 0.04±0.07 
Platelets cells10
3
/µl 1400.1±1.08 1400.3±4.84 1400.2±4.60 1400.4±6.32 
Total RBC 10
6
/µl 9.32±0.64 9.32±0.652 9.65±0.08 9.66±0.05 
PCV% 34.60±0.8 34.63±6.23 34.6±1.31 34.8±8.22 
MCHC g/dl 35.2±1.42 35.4±1.22 35.6±1.52 35.8±1.23 
MCV fl(µm
3
) 54.8±1.21 54.8±1.20 54.6±1.11 54.7±1.10 
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BIOCHEMICAL 
PARAMETERS 
CONTOL LOW DOSE MID DOSE HIGH DOSE 
HDL 24.12±2.30 24.12±2.30 24.16±1.42 24.65±1.34 
Ratio1(T.CHO/HDL) 5.1±1.10 5.1±1.20 5.1±1.30 5.1±1.60 
Ratio 2(LDL/HDL) 2.85±2.13 2.85±1.20 2.85±2.20 2.85±04.02 
Albumin(g/dL) 3.2±0.10 3.4±0.64 3.5±4.80 3.7±3.24 
        
           **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way ANOVA 
followed by Dunnett’s test) 
 
        Table No.30. Renal function test of of Wistar albino rats group exposed to MC 
 
 
 
 
 
 
 
 
NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
      Table No.31. Liver Function Test of of Wistar albino rats group exposed to MC 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
T.BILIRUBIN (mg/dl). 0.07±0.07 0.07±0.02 0.07±0.04 0.07±0.01 
SGOT/AST(U/L) 132.1±1.33 132.2±0.32 132.4±1.33 132.6±1.43 
SGPT/ALT(U/L) 99.10±1.44 99.14±1.10 99.24±1.64 99.23±0.20 
ALP(U/L) 182.40±1.12 182.2±1.14 183±1.24 184.3±2.51 
T.PROTEIN(g/dL) 6.5±0.13 6.5±0.21 6.7±0.32 6.7±0.34 
        NS- Not Significant, ** (p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
UREA (mg/dl) 22.11±0.10 23.10±0.15 23.16±1.22 24.12±1.63 
CREATININE(mg/dl) 0.6±0.02 0.7±0.03 0.7±0.05 0.9±0.09 
BUN(mg/dl) 27.5±0.03 28.5±0.14 28.2±0.30 28.6±1.40 
URIC ACID(mg/dl) 6.04±0.02 6.1±0.20 6.1±0.30 6.2±0.60 
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Discussion of Sub-acute toxicity study 
Sub-acute oral toxicity repeated dose of MC on rats were conducted. All animals 
from the treated dose survived throughout the dosing period of 28 days. Various 
parameters were studied and the interpretation of the study result is discussed below. 
Body weight 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight gain throughout the dosing period 
of 28 days. The quantity of food taken by the animals from different dose groups and 
the control is comparably normal. 
Haematological investigation interpretation 
The haematological investigation results of the rats conducted on 28
th
 day after 
the repeated dose of the drug revealed the values of different parameters. There is a 
slight variation in the values of RBC count values in the dose group of 200 and 400 
when compared with that of the control. The increase and decrease in the values 
obtained were all within the normal biological and laboratory limits. 
Biochemical investigation interpretation 
The biochemical investigations were conducted on 28
th
 day and the results are 
produced. The results revealed that there is no significant changes in the values of 
different parameters with that of the control. All the values were within the normal 
biological and laboratory limits. 
Urine analysis 
Urine analysis data of control group and the test groups of animals taken on 28
th
 
day showed no abnormal results. 
HISTOPATHOLOGY 
Furthermore no dose related histo pathological changes were observed. Gross 
examination in necropsy and at microscopic examination revealed no changes that 
attribute to the administration of drug.  
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No abnormal changes observed in the behavior of rats.The haematological, 
biochemical parameters, body weight are all remains in the normal level. After the drug 
administrations, the histopathological findings were analyzed and those also revealed no 
abnormal findings.  
This indicates that there is no observed level of toxicity findings at these fixed 
dose levels of low dose 100 mg and high dose 200 mg. Hence the study confirms that 
there is no observed level of toxicity in the 28 days repeated oral drug administration. 
The above slides show the histopathology studies of sub-acute toxicity. There is 
no toxicological abnormality seen in the vital organs after administration of the test drug 
MC. Thus the safety of the drug is revealed, so that it can be administered for long time 
without any side effects. 
Pharmacological Study 
Evaluation of anti-hypertensive activity of Siddha compound MC in Spontaneous 
Hypertensive rats 
Table No.32. Effect on Systolic Blood Pressure (SBP) of MC on various        
treatment groups on SHR rats 
S.no Treatment group SBP (mm Hg) 
1 Control 240.3±6.15 
2 MC 100mg/kg b.w 148.4±4.24** 
3 MC 200mg/kg b.w 130.2±2.42*** 
4 Verapamil hydrochloride12.5 mg/kg b.w 125.2±2.28*** 
 
Values represent mean ± SEM of 6 experiments. 
* P< 0.05; ** P˂ 0.01; *** P < 0.001, treatment versus control group 
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Graph No.5. Effect of Systolic Blood Pressure (SBP) of MC on various treatment 
groups on SH-rats at 28
th
 day 
 
Table No.33. Effect on Heart rate (HR) of MC on various treatment groups       
on   SHR rats 
S.no Treatment group Heart rate (beats/min) 
1 Control 520.2±4.21 
2 MC100mg/kg b.w 380.4±1.22** 
3 MC 200mg/kg b.w 340.2±1.11*** 
4 Verapamil hydrochloride 12.5 mg/kgb.w 330.1±3.34*** 
 
Values represent mean ± SEM of 6 experiments. 
               * P< 0.05; ** P˂ 0.01; *** P < 0.001, treatment versus control group 
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Graph No.6. Effect on Heart rate (HR) of MC on various treatment groups 
on SH-rats at 28
th
 day 
 
 
Interpretation: 
 The systolic blood pressure and heart rate were recorded in the conscious animals 
by non-invasive tail cuff method. 
 The results  reveals that the MC exhibits antihypertensive effect in the form of        
significant lower in systolic blood pressure and heart rate after continued 
administration for 7 days. 
 Heart rate was  also decreased significantly in comparison to control 
 The reduction in systolic blood pressure was measured and tabulated .The reading 
were compared with control group 
 The systolic blood pressure on 7th day in group III treated with MC 200m/kg body 
weight showed moderate reduction in  Systolic blood pressure compared with 7
th
 
day of control 
 But the reduction Systolic blood pressure measured on 21st day of MC 200mg /kg 
body weight treated group showed significant reduction of Systolic blood pressure 
compared with 21
st
 day of control group persistance highly significant 
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antihypertensive effect was noticed even after cessation of dosing 7 days earlier. 
This suggests absence of rebound phenomenon after withdrawal of the test drug 
MC which an advantage in the therapy of hypertension. 
 The Siddha herbomineral formulation MC, according to their traditional uses and 
phytochemical constituents based on their therapeutic value leads to discovery of 
newer and safer alternative drug and herbal medicines having a protective role in 
cardiovascular diseases
[94]
.
 
DIURETIC ACTIVITY:
 
Lipschitz et al was employed this method for the assessment of diuretic activity. 
The animals were deprived of food and water for 16tn hours prior to the experiment. 
Before oral administration of test drug the animals were dosed with 25ml/kg body 
weight of normal saline. The total volume of was measured. The urinary pH, sodium, 
potassium and chloride also determined. The result diuretic activity of MC was derived 
and tabulated below. 
 
Table No.34. Effect on urine volume of MC on various treatment groups on 
SH-rats 
       Groups 
Urine volume 
   (ml) 
Urine Ph 
Diuretic 
Index 
(T/C) 
       Control 2.45±0.10 7.44±0.16 - 
      Standard 6.35±0.17*** 7.50±1.28 2.59 
       MC 100 4.75±0.18** 7.22±0.40 1.93 
       MC 200 5.26±0.16*** 7.42±0.52 2.14 
 
Values represent mean ± SEM of 6 experiments.* P< 0.05; ** P˂ 0.01; *** P < 0.001, 
             treatment  versus control group 
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Graph No.3.Effect on urine volume of MC on various treatment groups on 
SH-rats 
 
Table No.35.  Effect on urine electrolyte excretion of MC on various treatment 
groups on SH-rats 
 
Groups 
Concentration of ions (mEq/l) Saluretic Index Na
+
/K
+ 
Na K Cl Na K Cl  
Control 19.84±1.57 24.45±1.49 87.37 ± 2.9 - - -  
Standard 66.76±1.96
** 
96.18±1.65
*** 
153.02±1.5
*** 
3.36 3.93 1.75 0.69 
MC 100 31.72±2.10
* 
75.12±1.42
* 
93.77±1.5
* 
1.59 3.07 1.07 0.42 
MC 200 54.41±2.53
** 
86.73±1.12
** 
115.12±3.9
** 
2.74 3.54 1.31 0.62 
 
Values represent mean ± SEM of 6 experiments.* P< 0.05; ** P< 0.01; *** P < 0.001, 
treatment versus control group 
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Graph No.4.Effect on urine electrolyte excretion of MC on various treatment 
groups on SH-rats 
 
Table no.36.Effect on BUN and Creatinine excretion of MC on  various treatment 
groups on SH-rats 
                          
Groups BUN Creatinine 
Control 140.1±1.4 29.2±0.8 
Standard 83.8±1.5** 40.7±0.5** 
MC 100 91.6±2.5* 32.1±0.8* 
MC 200 84.3±1.04* 34.05±1.6** 
 
Values represent mean ± SEM of 6 experiments.* P< 0.05; ** P˂ 0.01; *** P < 0.001, treatment versus 
control group 
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Graph No.5.Effect on BUN and Creatinine excretion of MC on  various 
treatment groups on SH-rats 
 
Interpretation: 
 The results of diuretic activity of MC showed marked increase in urine volume 
 There was no evidence of dehydration of animals were found, observed normal 
at 5 hours and 24 hours interval. 
 The standard diuretic Frusemide significantly increased in urine output when 
compared to normal 
 The test drug MC at 100mg/kg b.w,200mg/kg b.w doses, showed statistically 
significant increase in the  volume of urine with a dose dependant manner 
 There is significant change in the pH level of urine 
 Excretion of Na+, Cl- followed by similar pattern. Chloride excretion highly 
significant with two doses 
 The diuretic activity of MC 5 hours after its administration was manifested in 
the form of an increase in urinary volume, which was highly significant with 
100mg/kg b.w,200mg/kg b.w doses at 5 hours urine analysis 
 Analysis of 24 hours post dosing urine sample revealed similar results with 
regards to urinary volume, sodium, chloride and potassium are observed in 5
th
 
hour sample. That indicates a continuation of diuretic effect of MC upto 24 
hours. 
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 An herbal preparation usually contains many active components (flavanoids, 
alkaloids, quinones etc)the  phyto chemical analysis of MC shows significant 
presence of these compounds which either alone or in combination is 
responsible for the diuretic activity 
 The  diuretic study result of MC clearly indicates, that possesses potential 
diuretic activity on SH-rats and diuretics agents plays an important role in 
decreasing high blood pressure by decreasing plasma volume and also reducing 
cardiac work load and the oxygen demand
[95] [96]
 
 
ANTI-OXIDANT STUDY (In-Vitro) 
Different volumes (1.25-20µg/µl) of MC extracts were made up to 40µl with 
DMSO and 2.96ml DPPH (0.1mM) solution was added. There action mixture was 
incubated in dark condition at room temperature for 20min. After 20min, the absorbance 
of the mixture was read at 517 nm. 3ml of DPPH was taken as control. The % radical 
scavenging activity of the MC extracts was calculated using the following formula, 
 
       Control-Test 
% inhibition =            × 100 
           Control 
 
       Table No.37. DPPH Assay of MC 
 
 
Sample 
concentration(µg/ml) 
Absorbance % of Inhibition 
Drug Standard Drug Standard 
Control 0.5461 0.324         -           - 
       1.25 0.4641 0.242 15.015 25.30 
      2.50 0.3761 0.190 31.129 41.35 
          5 0.2040 0.125 62.644 61.41 
        10 0.1715 0.90 68.595 72.22 
         20 0.1009 0.45 81.523 86.11 
*µg/ml:microgram per millilitre. Drug : MC(1.25-20µg/µl).Standard: Ascarbic 
acid(10mg/ml DMSO) 
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Graph.No.6. DPPH Assay of MC 
 
DPPH stable free radical method is an easy, rapid and sensitive way to survey 
the antioxidant activity of MC extract.  The  antioxidant  molecules can  quench  DPPH 
free radicals by providing hydrogen  atomor by electron  donation and a colourless 
stable molecule 1, 1 diphenyl-2-picrylhydrazil is formed and as a result of which the 
absorbance at 517nm of the solution is decreased. 
In the present study, the extract of MC was found to possess concentration 
dependent scavenging activity on DPPH radicals. The values of DPPH free radical 
scavenging activity of the MC extract was given in (Table.37). The extract of MC 
showed the highest DPPH scavenging activity (81.52%) at 20µg/m and the lowest  
percentage of inhibition (15.01%)at 1.25µg/ml. Ascorbic acid (Standard) showed 
highest percentage of inhibition (86.11%) at 20µg/ml and the lowest percentage of 
inhibition (25.30%)at1.25µg/ml. This indicated that % of inhibition increased within 
crease in concentration of both the standard and MC extract.  The MC extract has 
more or less equal DPPH scavenging activity when compared to the standard. From 
the present study, it was concluded that the MC extract has a marked 
antioxidant activity at higher concentrations. Antioxidant compounds are highly 
present in plants and have protective effect s against diseases without reducing their 
therapeutic efficacy
[97]
.  So, using of  natural antioxidant as a protective strategy 
against cardiovascular related problems
[98]
. 
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7. CONCLUSION 
Herbals are always plays a significant role in the treatment of human diseases. 
Munthirikai Chooranam is a Siddha herbo mineral formulation indicated to treat 
hypertension, vertigo etc., Though  herbal medicines are always considered as safe for 
human health, it is essential to scientifically validate the herbal medicines for global 
acceptance.  The  Siddha drug was subjected to many analytical studies to scientifically 
validate its nature especially its medicinal value. 
The organoleptic characters of Munthirikai Chooranam has some features such as 
brown, aromatic, astringent, fine powder. The prepared drug statisfies the property of 
Chooranam. So the drug is easily soluble in nature. the aqueous extract of Munthirikai 
Chooranam confirms the presence of some phytochemical such as  Alkaloid, Glycosides, 
Phenol, Triterpene, Flavonoid, Quinine, Protein in the sample. These identified 
phytocomponents may chiefly responsible for its therapeutic action. The HPTLC analysis 
of this sample shows the components in this sample free from impurities. These radicals 
such as Potassium, Calcium, Magnesium, Sodium, Iron, Zinc, Sulphate, Chloride are 
present in this Munthirikai Chooranam. These identified elements helps to treat diseases. 
In microbial load analysis the bacterial load and fungal load were found to be within the 
normal range. 
 Sophisticated analytical equipments helps to identify the molecular nature of the 
drug. Using FTIR analysis the functional group such as alcohol, alkane, acid, alkyl 
halide, aromatic, amine, alkenes were identified in this drug. The identified each and 
every functional group plays a significant impact in the treatment of this disease. SEM 
images shows the surface morphology of the drug and XRD  findings reveals crystallinity 
of the drug. The presence of Aluminium, Arsenic, Calcium, Cadmium, Copper, Iron, 
Mercury, Potassium, Magnesium, Sodium, Nickel, Lead, Phosphorus, Sulphur Were 
Quantitatively Measured And The Presence Of Heavy Metals Such As Mercury, Arsenic,  
Lead, Cadmium were identified within the WHO permissible limits through ICPOES 
analysis. This clearly confirms that the drug can be administered in human to treat  
various diseases in a safe manner. These findings are creating the fingerprints for the 
Standardization of this  Siddha drug Munthirikai Chooranam. 
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In toxicological studies, the acute and 28 days repeated oral toxicity study  was carried 
out according to OECD guidelines to evaluate the safety of  Siddha drug Munthirikai 
Chooranam. There is no mortality seen  during acute toxicity study. No remarkable 
abnormal toxicity findings were  observed during the conduction of 28 days repeated oral 
toxicity study  in Siddha drug Munthirikai Chooranam. So, the toxicological study  
confirmed that the Siddha drug Munthirikai Chooranam is free from toxicity. So the drug 
is safe for human use. 
The anti-hypertensive potential of Munthirikai Chooranam was confirmed by the 
pharmacological study conducted on SHR rats. The diuretic activity and anti oxidant 
property of Munthirikai Chooranam was proved by study conducted using Lipchitz 
method and DPPH assay respectively. 
 Hence through these research works, the safety of the drug  and the anti-hypertensive, 
diuretic and antioxidant nature of the drug was evaluated. This Siddha herbo mineral drug 
Munthirikai Chooranam can helps to treat hypertensive patients. 
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SUMMARY 
Munthirikai chooranam is a wonderful Siddha herbo mineral formulation which is 
indicated  in Siddha texts as a best drug of choice to treat hypertension, vertigo etc.,  in 
order to scientifically evaluate this formulation, this drug undergoes physico chemical 
standardization, toxicity and pharmacological activity. 
1. The organoleptic characters of the drug Munthirikai Chooranam was 
observed as brown, aromatic, astringent, fine powder, completely pass 
through sieve no 88 in nature. 
2. The drug possess pH is 5.02, soluble in nature. 
3. In phytochemical analysis the aqueous extract showed the presence of 
Alkaloid, Glycosides, Phenol, Triterpene, Flavonoid, Quinine, Protein in the 
sample MC. 
4. The HPTLC analysis shows the fingerprints of the compounds present in the 
sample. 
5. The presence of basic radicals such as Potassium, Calcium, Magnesium, 
Sodium, Iron, Zinc were identified in this Munthirikai Chooranam. 
6. The presence of acid radicals such as Sulphate, Chloride, Nitrate were 
identified in this drug. 
7. In microbial load analysis, the bacterial and fungal load found within the 
normal limits. This confirms that the drug is safe for clinical use. 
8. The FTIR characterization of the Siddha medicinal compound Munthirikai 
Chooranam confirms that the presence of some functional groups such as 
alcohol, alkane, acid, alkyl halide, aromatic, amine, alkenes. 
9. SEM analysis confirms the surface morphology of the drug. 
10. The XRD analysis confirms the crystalline nature of the drug. 
11. The results of ICPOES study shows the presence of Aluminium, Arsenic, 
Calcium, Cadmium, Copper, Iron, Mercury, Potassium, Magnesium, 
Sodium, Nickel, Lead, Phosphorus, Sulphur. The heavy metals such as Lead, 
Arsenic, Mercury, Cadimium were identified as within the WHO permissible 
limits. This clearly explains that the drug Munthirikai Chooranam is safe for 
therapeutic usage. 
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12. There is no toxicity findings at the acute toxicity level determination. Based 
on OECD 423 the trail drug Munthirigai Chooranam is considered non toxic 
up to the dose of 2000mg/kg.    
13. In 28 days repeated dose oral toxicity study in rats to evaluate the toxicity 
findings of the drug, the haematological, biochemical parameters, body 
weight are all remains in the normal level. After the drug administration, the 
histopathological findings were analyzed and those also revealed no 
abnormal findings. This indicates that there is no observed level of toxicity 
findings at these fixed dose levels of low dose 100 mg and high dose 200 
mg. Hence the study confirms that there is no observed level of toxicity in 
the 28 days repeated oral drug administration. From toxicological study 
results the drug is free from toxic effects for human use at therapeutic dose 
level. 
14. In  SHR rats, the drug Munthirikai Chooranam reduces the blood pressure 
and heart rate in a dose dependant manner. This clearly explains that this 
Siddha medicinal compound having strong anti-hypertensive potential. 
15. In DPPH assay , the drug Munthirikai Chooranam possess potent antioxidant 
property comparably higher than the synthetic antioxidant BHT. This 
confirms the antioxidant nature of the drug. 
 These research works confirms that the drug is safe for clinical use. And the studies 
possess that the Siddha herbo mineral formulation Munthirikai Chooranam has anti 
hypertensive, diuretic and anti oxidant property. 
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FUTURE  SCOPE 
Munthirikai Chooranam is a Siddha medicinal compound has no toxic effects and it  
has anti-hypertensive, diuretic and antioxidant property. The preparation of the drug is 
simple and cost effective. The research findings will be helpful in getting the knowledge 
regarding the molecular nature of the drug. The drug has promising therapeutic potential 
to manage hypertension which is highly prevalence nowadays. Followed by these 
research findings, if clinical trial will be conducted to manage hypertension in future 
this drug Munthirikai Chooranam can contribute a lot to the society. 
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